<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31001316</article-id>
<article-id pub-id-type="pmc">6456656</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2019.00258</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>De novo</italic> Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Weidi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/556673/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Corominas</surname>
<given-names>Roser</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/707070/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Guan Ning</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/585706/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Shanghai Mental Health Center, School of Biomedical Engineering, Shanghai Jiao Tong University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Brain Science and Technology Research Center, Shanghai Jiao Tong University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Departament de Genètica, Microbiologia i Estadística, Facultat de Biologia, Universitat de Barcelona</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff>
<aff id="aff5"><sup>5</sup><institution>Centro de Investigación Biomédica en Red de Enfermedades Raras</institution>, <addr-line>Valencia</addr-line>, <country>Spain</country></aff>
<aff id="aff6"><sup>6</sup><institution>Institut de Biomedicina de la Universitat de Barcelona</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff>
<aff id="aff7"><sup>7</sup><institution>Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Prashanth N. Suravajhala, Birla Institute of Scientific Research, India</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Apostolos Zaravinos, European University Cyprus, Cyprus; Ashwani Mishra, Independent Researcher, New Delhi, India</p>
</fn>
<corresp id="c001">*Correspondence: Guan Ning Lin <email>nickgnlin@sjtu.edu.cn</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Bioinformatics and Computational Biology, a section of the journal Frontiers in Genetics</p>
</fn>
<fn fn-type="other" id="fn002">
<p>†These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>258</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Wang, Corominas and Lin.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Wang, Corominas and Lin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Neurodevelopmental and psychiatric disorders are a highly disabling and heterogeneous group of developmental and mental disorders, resulting from complex interactions of genetic and environmental risk factors. The nature of multifactorial traits and the presence of comorbidity and polygenicity in these disorders present challenges in both disease risk identification and clinical diagnoses. The genetic component has been firmly established, but the identification of all the causative variants remains elusive. The development of next-generation sequencing, especially whole exome sequencing (WES), has greatly enriched our knowledge of the precise genetic alterations of human diseases, including brain-related disorders. In particular, the extensive usage of WES in research studies has uncovered the important contribution of <italic>de novo</italic> mutations (DNMs) to these disorders. Trio and quad familial WES are a particularly useful approach to discover DNMs. Here, we review the major WES studies in neurodevelopmental and psychiatric disorders and summarize how genes hit by discovered DNMs are shared among different disorders. Next, we discuss different integrative approaches utilized to interrogate DNMs and to identify biological pathways that may disrupt brain development and shed light on our understanding of the genetic architecture underlying these disorders. Lastly, we discuss the current state of the transition from WES research to its routine clinical application. This review will assist researchers and clinicians in the interpretation of variants obtained from WES studies, and highlights the need to develop consensus analytical protocols and validated lists of genes appropriate for clinical laboratory analysis, in order to reach the growing demands.</p>
</abstract>
<kwd-group>
<kwd>whole exome sequencing</kwd>
<kwd>neurodevelopmental and psychiatric disorder</kwd>
<kwd><italic>de novo</italic> mutation</kwd>
<kwd>network analysis</kwd>
<kwd>clinical implementation</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="3"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="222"></ref-count>
<page-count count="19"></page-count>
<word-count count="16674"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The susceptibility to neurodevelopmental and psychiatric (NDP) disorders involves polygenic, multi-effect, and complex genetic structures. Large-scale twin and population-based studies were able to show that genetics accounts for 30–80% of disease liability for many neuropsychiatric disorders (Gandal et al., <xref ref-type="bibr" rid="B48">2016</xref>). An early indication of the genetic involvement in major NDP disorders was their association with rare Mendelian disorders, each with distinctive morphologic, cognitive, and neuropsychiatric phenotypes, such as Fragile X, Angelman, or Rett syndromes (De Boulle et al., <xref ref-type="bibr" rid="B31">1993</xref>; De Hert et al., <xref ref-type="bibr" rid="B32">1996</xref>; Inoue and Lupski, <xref ref-type="bibr" rid="B78">2003</xref>; Betancur, <xref ref-type="bibr" rid="B15">2011</xref>; Blair et al., <xref ref-type="bibr" rid="B16">2013</xref>). Due to the limited power and systematic confounders such as population stratification bias, the early linkage and candidate gene studies often yielded disperse findings (Kohler and Bickeboller, <xref ref-type="bibr" rid="B92">2006</xref>; Price et al., <xref ref-type="bibr" rid="B146">2010</xref>). In contrast, the unbiased large-scale genome-wide interrogation, such as genome-wide association studies (GWAS), of common genetic variation in large cohorts has become a popular detection methodology and study design to identify risk factors in neuropsychiatric diseases, such as autism spectrum disorders (ASD), schizophrenia (SCZ), intellectual disability, and/or developmental delay (ID/DD), obsessive-compulsive disorder (OCD) or bipolar disorder (BD) and has yielded more robust results (Epi4k Consortium et al., <xref ref-type="bibr" rid="B39">2013</xref>; Schizophrenia Working Group of the Psychiatric Genomics Consortium et al., <xref ref-type="bibr" rid="B161">2014</xref>; Hou et al., <xref ref-type="bibr" rid="B75">2016</xref>; Liu et al., <xref ref-type="bibr" rid="B111">2016a</xref>; The Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium, <xref ref-type="bibr" rid="B186">2017</xref>; Trampush et al., <xref ref-type="bibr" rid="B188">2017</xref>; Ikeda et al., <xref ref-type="bibr" rid="B77">2018</xref>; Pasman et al., <xref ref-type="bibr" rid="B142">2018</xref>). Interesting GWAS discoveries have been made on a wide variety of neuropsychiatric disorders and clinical traits, many of which have been covered in other in-depth reviews (Sullivan, <xref ref-type="bibr" rid="B178">2010</xref>; Visscher et al., <xref ref-type="bibr" rid="B197">2012</xref>, <xref ref-type="bibr" rid="B198">2017</xref>; Collins and Sullivan, <xref ref-type="bibr" rid="B26">2013</xref>; Horwitz et al., <xref ref-type="bibr" rid="B74">2018</xref>). Therefore, the scope of our review is mainly focused on the usage of next generation sequencing (NGS) technology, specifically whole exome sequencing (WES), as an additional approach in neuropsychiatric disorder studies, in an attempt to uncover the missing genetic basis of the disease etiology. There are two commonly used study strategies for discovering disease-associated variants using WES. One is the exome case-control study to find the rare inherited variants, which usually require a large sample size to identify the significant variants, such as in SCZ (Genovese et al., <xref ref-type="bibr" rid="B49">2016</xref>), BD (Goes et al., <xref ref-type="bibr" rid="B57">2016</xref>), and OCD (McGrath et al., <xref ref-type="bibr" rid="B118">2014</xref>). A comprehensive review has been done by Gratten et al. (<xref ref-type="bibr" rid="B60">2014</xref>) on exome case-control studies and has contributed greatly to our understanding of neuropsychiatric diseases. The other one, is the <italic>de novo</italic> variants (DNV) discovery, based on trio/quad studies with relatively smaller sample sizes as an alternative strategy with great success in disorders, such as ASD (De Rubeis et al., <xref ref-type="bibr" rid="B34">2014</xref>; Iossifov et al., <xref ref-type="bibr" rid="B81">2014</xref>; O'Roak et al., <xref ref-type="bibr" rid="B134">2014</xref>) and ID/DD (Gilissen et al., <xref ref-type="bibr" rid="B52">2014</xref>; Short et al., <xref ref-type="bibr" rid="B169">2018</xref>). Thus, in this review, we focus on the DNV studies, their significance and clinical translations. Here, we summarize the recent repertoire of <italic>de novo</italic> events detected from WES family-based trio (two unaffected biological parents and the affected child) or quad (two unaffected biological parents, the affected child, and one unaffected sibling) studies in NDP disorders and provide a detailed overview of some of the most successful integrative methods for DNM analyses. Finally, we also review the current state of WES application in NDP disorder clinical diagnosis.</p>
</sec>
<sec id="s2">
<title>Dissecting Neurodevelopmental and Psychiatric Disorders by Identifying <italic>de novo</italic> Rare Genetic Variants</title>
<sec>
<title>Usage of Whole Exome Sequencing in NDP Disorders to Detect DNMs</title>
<p>Over the past decade, NGS has become increasingly popular for estimating the genetic etiology of Mendelian, complex, and undiagnosed disorders due to its scale and comprehensiveness (Bamshad et al., <xref ref-type="bibr" rid="B10">2011</xref>; Goldstein et al., <xref ref-type="bibr" rid="B58">2013</xref>; MacArthur et al., <xref ref-type="bibr" rid="B115">2014</xref>; Zhu et al., <xref ref-type="bibr" rid="B222">2014</xref>). In WES, the ~1.5% of the genome, encoding for proteins, is captured and then sequenced at lower costs and increases the interpretability of the identified variants, in contrast to the much more expensive whole genome sequencing (WGS) that surveys the entire genome space. To facilitate interpretation and decrease the cost of the whole genome sequencing (WGS), the portion of the genome related to protein coding regions is captured and sequenced in WES. Notably, studies of NDP disorders using WES and WGS have indicated that <italic>de novo</italic> mutations (DNMs) detected from trio- or quad-based familiar studies have important roles (<xref ref-type="table" rid="T1">Table 1</xref>), despite the genetic heterogeneity of types of disorders (Sullivan et al., <xref ref-type="bibr" rid="B179">2012a</xref>; Gratten et al., <xref ref-type="bibr" rid="B59">2013</xref>). Filtering DNV in a proband against unaffected parents, facilitates the interpretation of potential <italic>de novo</italic> pathogenic variants among all the detected ones (<xref ref-type="fig" rid="F1">Figure 1A</xref>). For example, Neale and colleagues (Neale et al., <xref ref-type="bibr" rid="B128">2012</xref>) performed one of the four first large WES cohort studies using a trio-based design to investigate the contribution of DNMs to ASD (Iossifov et al., <xref ref-type="bibr" rid="B82">2012</xref>; Neale et al., <xref ref-type="bibr" rid="B128">2012</xref>; O'Roak et al., <xref ref-type="bibr" rid="B136">2012b</xref>; Sanders et al., <xref ref-type="bibr" rid="B159">2012</xref>), which showcased the important role of DNMs in the pathogenesis of ASD. More importantly, Neale and colleagues also proposed a statistical framework to analyze whether individual genes carry significantly more DNMs than expected by chance. Furthermore, Sanders et al. estimated that penetrant DNMs in genes contribute to autism risk in ~11% of parent-child trio families (Sanders et al., <xref ref-type="bibr" rid="B158">2015</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Summary of published studies of DNMs found in large cohorts of patients with psychiatric disorders.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Study</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Clinical phenotype<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Number of individuals</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Probands/controls</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Sequencing method</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Vissers et al., <xref ref-type="bibr" rid="B199">2010</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">MR</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B133">2011</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">20</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B133">2011</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">20</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Girard et al., <xref ref-type="bibr" rid="B54">2011</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">14</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Xu et al., <xref ref-type="bibr" rid="B213">2011</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">53</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Xu et al., <xref ref-type="bibr" rid="B213">2011</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">22</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sanders et al., <xref ref-type="bibr" rid="B159">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">238</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sanders et al., <xref ref-type="bibr" rid="B159">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">200</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B136">2012b</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">189</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B136">2012b</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">31</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neale et al., <xref ref-type="bibr" rid="B128">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">175</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Iossifov et al., <xref ref-type="bibr" rid="B82">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">343</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Iossifov et al., <xref ref-type="bibr" rid="B82">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">343</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kong et al., <xref ref-type="bibr" rid="B94">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD or SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">65</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rauch et al., <xref ref-type="bibr" rid="B149">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">51</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rauch et al., <xref ref-type="bibr" rid="B149">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">20</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">de Ligt et al., <xref ref-type="bibr" rid="B33">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">100</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Xu et al., <xref ref-type="bibr" rid="B212">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">231</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Xu et al., <xref ref-type="bibr" rid="B212">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">34</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Barcia et al., <xref ref-type="bibr" rid="B11">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">EE</td>
<td align="center" colspan="1" rowspan="1" valign="top">12</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B135">2012a</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">2446</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Michaelson et al., <xref ref-type="bibr" rid="B120">2012</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Veeramah et al., <xref ref-type="bibr" rid="B195">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">EE</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Jiang et al., <xref ref-type="bibr" rid="B85">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">32</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gulsuner et al., <xref ref-type="bibr" rid="B64">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">105</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gulsuner et al., <xref ref-type="bibr" rid="B64">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">84</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Epi4k Consortium et al., <xref ref-type="bibr" rid="B39">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">EE</td>
<td align="center" colspan="1" rowspan="1" valign="top">264</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fromer et al., <xref ref-type="bibr" rid="B45">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">623</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">McCarthy et al., <xref ref-type="bibr" rid="B117">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">57</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Takata et al., <xref ref-type="bibr" rid="B182">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">231</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gilissen et al., <xref ref-type="bibr" rid="B52">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">50</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Francioli et al., <xref ref-type="bibr" rid="B44">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">250</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Appenzeller et al., <xref ref-type="bibr" rid="B6">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">EE</td>
<td align="center" colspan="1" rowspan="1" valign="top">356</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hamdan et al., <xref ref-type="bibr" rid="B68">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">41</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B34">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">2303</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Iossifov et al., <xref ref-type="bibr" rid="B81">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">2500</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Iossifov et al., <xref ref-type="bibr" rid="B81">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">1911</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B134">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">3486</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B134">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">3486</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">O'Roak et al., <xref ref-type="bibr" rid="B134">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">2493</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Guipponi et al., <xref ref-type="bibr" rid="B63">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">53</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Yuen et al., <xref ref-type="bibr" rid="B218">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">170</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">van Bon et al., <xref ref-type="bibr" rid="B192">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">7162</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Krumm et al., <xref ref-type="bibr" rid="B97">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">2377</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Krumm et al., <xref ref-type="bibr" rid="B97">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">1786</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Parker et al., <xref ref-type="bibr" rid="B141">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kranz et al., <xref ref-type="bibr" rid="B95">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">14</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kun-Rodrigues et al., <xref ref-type="bibr" rid="B98">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Parkinson early-onset</td>
<td align="center" colspan="1" rowspan="1" valign="top">21</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hashimoto et al., <xref ref-type="bibr" rid="B69">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">30</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Turner et al., <xref ref-type="bibr" rid="B190">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">53</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Turner et al., <xref ref-type="bibr" rid="B190">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">43</td>
<td align="left" colspan="1" rowspan="1" valign="top">control</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Helbig et al., <xref ref-type="bibr" rid="B71">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">EE</td>
<td align="center" colspan="1" rowspan="1" valign="top">1131</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cappi et al., <xref ref-type="bibr" rid="B19">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">OCD</td>
<td align="center" colspan="1" rowspan="1" valign="top">20</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kataoka et al., <xref ref-type="bibr" rid="B88">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">BD</td>
<td align="center" colspan="1" rowspan="1" valign="top">79</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tlemsani et al., <xref ref-type="bibr" rid="B187">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">210</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Halvardson et al., <xref ref-type="bibr" rid="B66">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">39</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lelieveld et al., <xref ref-type="bibr" rid="B105">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">820</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Yuen et al., <xref ref-type="bibr" rid="B217">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">200</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Wang et al., <xref ref-type="bibr" rid="B203">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">1045</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Deciphering Developmental Disorders Study et al., <xref ref-type="bibr" rid="B35">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">DD</td>
<td align="center" colspan="1" rowspan="1" valign="top">4293</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stessman et al., <xref ref-type="bibr" rid="B175">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">4787</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stessman et al., <xref ref-type="bibr" rid="B175">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ID</td>
<td align="center" colspan="1" rowspan="1" valign="top">151</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stessman et al., <xref ref-type="bibr" rid="B175">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">DD</td>
<td align="center" colspan="1" rowspan="1" valign="top">1133</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Yuen et al., <xref ref-type="bibr" rid="B216">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">1740</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kim et al., <xref ref-type="bibr" rid="B89">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ADHD</td>
<td align="center" colspan="1" rowspan="1" valign="top">11</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B24">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">116</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lanoiselée et al., <xref ref-type="bibr" rid="B101">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer early-onset</td>
<td align="center" colspan="1" rowspan="1" valign="top">10</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">Targeted</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Willsey et al., <xref ref-type="bibr" rid="B209">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Tourette Disorder</td>
<td align="center" colspan="1" rowspan="1" valign="top">325</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nishi et al., <xref ref-type="bibr" rid="B131">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SCZ</td>
<td align="center" colspan="1" rowspan="1" valign="top">18</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WES</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hamdan et al., <xref ref-type="bibr" rid="B67">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">DEE</td>
<td align="center" colspan="1" rowspan="1" valign="top">197</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Werling et al., <xref ref-type="bibr" rid="B207">2018</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">ASD</td>
<td align="center" colspan="1" rowspan="1" valign="top">519</td>
<td align="left" colspan="1" rowspan="1" valign="top">proband</td>
<td align="left" colspan="1" rowspan="1" valign="top">WGS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>*</label>
<p><italic>ADHD, Attention-Deficit/Hyperactivity Disorder; ASD, Autism Spectrum Disorder; BD, Bipolar Disorder; ID, Intellectual Disability; DD, Developmental Delay; DEE, Developmental and Epileptic Encephalopathies; EE, Epilepsy; MD, Mental Retardation; OCD, Obsessive-Compulsive Disorder; SCZ, Schizophrenia</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>The analytical pipeline for DNMs detected from exome studies in psychiatric disorders. <bold>(A)</bold> The discovery flow of DNMs from trios, including sample collection, data Quality Control (QC), alignment, variants calling, annotation. <bold>(B)</bold> The functional annotation step, e.g., applying computational tools, such as SIFT and CADD to predict the functional consequences of the detected mutation. <bold>(C)</bold> The large-scale data integration step to investigate the underlying disease genetics. <bold>(D)</bold> The functional enrichment analyses and interpretation step, which help understand the disease etiology. <bold>(E)</bold> The functional studies phase is the experimental validation step. <bold>(F)</bold> The clinical application step of the DNM pipeline, which can utilize the verified DNMs as the mutation screening profile for clinical diagnosis in psychiatric patients.</p>
</caption>
<graphic xlink:href="fgene-10-00258-g0001"></graphic>
</fig>
</sec>
<sec>
<title>Summary of Published Exome DNMs in Neuropsychiatric Disorders</title>
<p>In the past few years, 66% of the large cohort studies that investigate DNMs of early onset psychiatric disorders published were carried out by WES, compared to only 18% by WGS and the remaining 16% by targeted sequencing, demonstrating the prominent role of the WES in mutation discovery (<xref ref-type="table" rid="T1">Table 1</xref>). These studies have identified, by the end of 2018 in denovo-db (Turner et al., <xref ref-type="bibr" rid="B191">2017</xref>), more than 57,300 DNMs in 44,200 individuals with a variety of neuropsychiatric disorders estimating a rate of ~1.3 DNMs/individual (<xref ref-type="table" rid="T1">Table 1</xref>). Also, the decrease in cost of NGS over the years has resulted in an explosion of small WES studies from limited collections or index cases from all over the world (Smedemark-Margulies et al., <xref ref-type="bibr" rid="B170">2016</xref>; Zhu et al., <xref ref-type="bibr" rid="B221">2018</xref>). Manual curation and time are needed for all these variants to progressively be introduced in variant databases, such as 1000 Genomes (Gibbs et al., <xref ref-type="bibr" rid="B51">2015</xref>), the National Heart Lung and Blood Institute's Exome Sequencing Project (ESP) (Exome Variant Server (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>), Database of Short Genetic Variations (dbSNP) (Sherry et al., <xref ref-type="bibr" rid="B166">2001</xref>), expert-curated databases focused on variant information (locus-specific databases; LSDB) (Fokkema et al., <xref ref-type="bibr" rid="B43">2011</xref>) or clinical information e.g., GeneReviews (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK1116/">http://www.ncbi.nlm.nih.gov/books/NBK1116/</ext-link>) and ClinVar (Landrum et al., <xref ref-type="bibr" rid="B100">2016</xref>), where mutations are deposited by submitters, or collected by the private Human Mutation Database (HGMD) (Stenson et al., <xref ref-type="bibr" rid="B174">2017</xref>). As for DNMs, a few databases are being developed hosting the collection of the DNMs across developmental and neuropsychiatric disorders and controls, such as denovo-db (Turner et al., <xref ref-type="bibr" rid="B191">2017</xref>) and NPdenovo (Li et al., <xref ref-type="bibr" rid="B107">2016</xref>). The same team also developed mirDNMR, a gene-centered database of background DNM rates in humans (Jiang et al., <xref ref-type="bibr" rid="B84">2017</xref>). Still, these databases focus on the variant information, such as locations and frequencies. Therefore, a freely available unified systematic variance repository collecting the results from all the currently published variants fast, including medically relevant information, is needed to ensure the rapid translation of novel information to researchers and clinicians.</p>
<p>DNMs including single nucleotide variants (SNVs) and small insertions/deletions (indels) in exonic regions, are rare and generally considered to have a stronger disruptive effect on biological functions than inherited variants (Crow, <xref ref-type="bibr" rid="B28">2000</xref>). Thus, DNMs provide a valuable insight into the genetic understanding and clinical interpretation of sporadic cases in which inheritance may be limited to explain disease etiology (Veltman and Brunner, <xref ref-type="bibr" rid="B196">2012</xref>; MacArthur et al., <xref ref-type="bibr" rid="B115">2014</xref>; Samocha et al., <xref ref-type="bibr" rid="B157">2014</xref>). As a result, the number of WES studies and identified DNMs have increased rapidly over the past few years (<xref ref-type="fig" rid="F2">Figure 2A</xref>). To facilitate the interpretation of DNMs from exonic and exon-flanking regions, they are usually categorized by their functional impacts (<xref ref-type="fig" rid="F2">Figure 2B)</xref> as synonymous (23%) or non-synonymous variants (77%). As the former mutations typically have a silent effect, even some of them may contribute to alternative splicing and protein fold change (Sauna and Kimchi-Sarfaty, <xref ref-type="bibr" rid="B160">2013</xref>), but their predictions are limited except biological experiments showing the results of these variants. Thus, we chose to focus on the non-synonymous DNMs. The latter is further classified into likely gene-damaging loss-of-function (LoF) variants (15%) (nonsense, frameshift indels, and splice-site mutations) and missense variants (62%). However, only a fraction of these DNMs is responsible for the clinical phenotypes. In an extensive study of &gt;2,500 simplex families with ASD, 43% of LoFs, and 13% of the missense DNMs were estimated to be pathogenic (Iossifov et al., <xref ref-type="bibr" rid="B81">2014</xref>). We observe that mutations from ASD and ID/DD contribute the most (86.6%) to the current repertoire of WES DNMs (<xref ref-type="fig" rid="F2">Figure 2A</xref>), which is not surprising since 85% of the trio/quad samples presented these disorders and have been more systematically interrogated than others. Also, the distribution of variant types identified is similar across disorders (<xref ref-type="fig" rid="F2">Figure 2B</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Summary of DNMs detected from exome studies in psychiatric disorders. <bold>(A)</bold> The overview of the numbers of WES studies in psychiatric disorders increased over the past few years (until the end of 2017). <bold>(B)</bold> The distribution of <italic>de novo</italic> LoF, missense, and synonymous mutations detected in four different disorders across large studies (<xref ref-type="table" rid="T1">Table 1</xref>). <bold>(C)</bold> Venn Diagram of the overlap of genes hit by DNMs from major studies of patients with psychiatric disorders. <bold>(D)</bold> The overlap between the genes carrying DNMs and genes hit by the <italic>de novo</italic> CNVs in four different disorders. ASD, Autism Spectrum Disorder; ID/DD, Intellectual Disability, Developmental Delay; SCZ, Schizophrenia; BD, Bipolar Disorder.</p>
</caption>
<graphic xlink:href="fgene-10-00258-g0002"></graphic>
</fig>
<p>The excessive comorbidity between various neuropsychiatric diagnoses, such as ASD, ID/DD, SCZ, BD, OCD, Tourette syndrome, and ADHD makes the interpretation of the underlining disease etiology extremely difficult (Ronald et al., <xref ref-type="bibr" rid="B153">2008</xref>; Lichtenstein et al., <xref ref-type="bibr" rid="B109">2010</xref>; Rommelse et al., <xref ref-type="bibr" rid="B152">2010</xref>; Faraone et al., <xref ref-type="bibr" rid="B40">2012</xref>; Sullivan et al., <xref ref-type="bibr" rid="B180">2012b</xref>; Chen et al., <xref ref-type="bibr" rid="B23">2016</xref>; Hirschtritt et al., <xref ref-type="bibr" rid="B72">2018</xref>; Liu and Wu, <xref ref-type="bibr" rid="B113">2018</xref>; Shen et al., <xref ref-type="bibr" rid="B165">2018</xref>). Another limiting factor is the large polygenicity of these diseases. Almost all NDP disorders are associated with potentially thousands of disease risk genes, each conferring variable effects. To this extent, accumulation of the genes carrying DNMs from WES in multiple NDP disorder studies provides an excellent opportunity for interrogating the underlying shared genetic component among various disorders. We used pLI scores (Lek et al., <xref ref-type="bibr" rid="B104">2016</xref>) to prioritize and summarize the overlapped genes. The pLI score of a given gene indicates the probability that it belongs in the haploinsufficient category, wherein a single functional copy of a gene is insufficient to maintain its normal function and is extremely intolerant of LoF variation. Thus, we summarized the overlapped genes (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>) with high pLI scores (pLI ≥ 0.9, extremely LoF intolerant) carrying DNMs between four different disorders, ASD, SCZ, ID/DD, and BP, in <xref ref-type="fig" rid="F2">Figure 2C</xref>.</p>
<p>The disorders that shared the larger number of genes are ASD and ID/DD, but these observations could be explained by the extensive shared clinical phenotypes. These observations need to be considered with caution due to a large number of WES studies performed in these disorders. There are some noticeable genes carrying DNMs in patients from at least three different disorders, such as Chromodomain Helicase DNA Binding Protein 8 <italic>CHD8</italic> (ASD, ID/DD, SCZ), Lysine Methyltransferase 2C <italic>KMT2C</italic> (ASD, BP, ID/DD, SCZ), Chromodomain Helicase DNA Binding Protein 5 <italic>CHD5</italic> (ASD, ID/DD, SCZ), Sodium Voltage-Gated Channel Alpha Subunit 2 <italic>SCN2A</italic> (ASD, ID/DD, SCZ), Neurexin 1 <italic>NRXN1</italic> (ASD, ID/DD, SCZ), or Period Circadian Regulator 1 <italic>PER1</italic> (ASD, BP, ID/DD), suggesting that some biological processes are probably shared between neuropsychiatric disorders.</p>
</sec>
<sec>
<title>Unique Contribution of <italic>de novo</italic> Events to the Understanding of Disease Etiology</title>
<p>A chromosomal structural variation (SV) is usually a rearrangement of a genomic region with variable size (50 bp−5 Mb) that can cause Mendelian disease and contribute to complex diseases (Stankiewicz and Lupski, <xref ref-type="bibr" rid="B172">2010</xref>; Girirajan et al., <xref ref-type="bibr" rid="B55">2011</xref>). It includes different types of alternations, such as inversions and balanced translocations or genomic imbalances (duplications and deletions), the latter commonly known as copy number variants (CNVs) (Weckselblatt and Rudd, <xref ref-type="bibr" rid="B205">2015</xref>). The advent of chromosomal microarrays enabled the detection of large genomic <italic>de novo</italic> structural variants such as recurrent <italic>de novo</italic> (or inherited) CNV in trio studies (e.g., 1q21.1, 16p11.2, or 22q11.21) or ultra-rare or unique <italic>de novo</italic> CNVs. These discoveries provided an additional aspect of disease etiology and brought rare variants with large effect sizes to the forefront (Malhotra and Sebat, <xref ref-type="bibr" rid="B116">2012</xref>). Especially with the advent of the high sequencing coverage, CNV calling from WES/WGS became more reliable (Trost et al., <xref ref-type="bibr" rid="B189">2018</xref>), and a machine-learning algorithm based software (SV2) improved performance of the SV detection, including CNV, for genotyping deletions and duplications from paired-end sequencing data (Antaki et al., <xref ref-type="bibr" rid="B5">2018</xref>; Brandler et al., <xref ref-type="bibr" rid="B18">2018</xref>). It has been estimated that CNVs are responsible for a considerable percentage of the genetic causes in some psychiatric disorders such as ~10% of simplex cases of ASD (Sebat et al., <xref ref-type="bibr" rid="B163">2007</xref>). However, <italic>de novo</italic> CNVs discovered in NDP disorders pose many challenges for interpretations, such as pleiotropy, incomplete penetrance, and difficulty to directly identify the pathogenic genes due to the fact that the affected region may contain no known gene (potentially affecting regulatory elements) or, on the contrary, a large and diverse set of genes. When overlapping the genes carrying DNMs from WES to the genes hit by <italic>de novo</italic> CNVs from arrays of four different disorders (ASD, BD, ID/DD, and SCZ), only &lt;30% of them are shared (<xref ref-type="fig" rid="F2">Figure 2D</xref>). These issues emphasize the need for different detection methods for interrogating the differential impact of molecular pathologies by different types of disease mutations. In consequence, WGS that covers the entire genome in trio or quad family-based studies is more comprehensive and capable of detecting a complete set of SNPs, SNVs, indels, and CNVs of an individual at the same time. Also, it could be a choice to replace the usual strategy of using multiple sequencing technologies to investigate all the variants in neuropsychiatric disorders.</p>
</sec>
</sec>
<sec id="s3">
<title>Interpreting rare genetic variants from exome studies</title>
<p>With the abundance of the genomic variants obtained from WES and WGS studies, one of the most significant challenges is to systematically interrogate the functional impact of the detected variants and identify the underlying affected pathway. Though the ultimate proof of DNMs contribution to the phenotypes is functional assays (<xref ref-type="fig" rid="F1">Figure 1E</xref>), these tests are generally difficult to implement in such large scales systematically. To overcome this limitation, computational methods have been developed to investigate DNMs consequences and involve typically multiple steps: evaluation of the DNMs potential pathogenicity; incorporation of other variants such as CNVs or inherited DNMs; and finally, integrative analyses of data from other sources of evidence to enhance the understanding of the disease functional pathways (<xref ref-type="fig" rid="F1">Figures 1B–D)</xref>.</p>
<sec>
<title>Prediction of Functional Consequences of DNMs</title>
<p>One of the most important steps when the variants are obtained, is to functionally annotate them to distinguish deleterious variants from a considerable number of variants from the neutral background. Numerous efforts have been carried out to develop computational tools to functionally interpret both coding and non-coding genomic elements and to estimate the variants pathogenicity, such as SIFT (Ng and Henikoff, <xref ref-type="bibr" rid="B129">2003</xref>), PolyPhen-2 (Adzhubei et al., <xref ref-type="bibr" rid="B2">2010</xref>), GERP (Davydov et al., <xref ref-type="bibr" rid="B30">2010</xref>), or CADD (Kircher et al., <xref ref-type="bibr" rid="B91">2014</xref>) (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Pathogenicity evaluation can be a challenging task as the estimated results of different methods sometimes lack of the consistency, and functional assays are not systematically performed. To this end, several studies (Gnad et al., <xref ref-type="bibr" rid="B56">2013</xref>; Dong et al., <xref ref-type="bibr" rid="B38">2015</xref>; Miosge et al., <xref ref-type="bibr" rid="B122">2015</xref>; Ionita-Laza et al., <xref ref-type="bibr" rid="B80">2016</xref>) have extensively reviewed these computational annotation tools. Some of these studies divide the multiple tools according to the variant types predictions (Richards et al., <xref ref-type="bibr" rid="B151">2015</xref>), while others compared non-coding genome pathogenicity scores using calculation methods based on machine learning approaches (Telenti et al., <xref ref-type="bibr" rid="B184">2018</xref>). These summaries often include widely used tools such as SIFT (Ng and Henikoff, <xref ref-type="bibr" rid="B129">2003</xref>), PolyPhen-2 (Adzhubei et al., <xref ref-type="bibr" rid="B2">2010</xref>), or MutationTaster2 (Schwarz et al., <xref ref-type="bibr" rid="B162">2014</xref>), which are based on the evolutionary conservation, which predicts the impacts by determining the conservation of an amino acid across species or based on protein 3D structures features, or both. Li et al. conducted a comprehensive evaluation of 23 methods for annotating missense variants using three independent benchmark datasets with 12 different performance measures (Li et al., <xref ref-type="bibr" rid="B108">2018</xref>) and indicated that ReVe, a combination of REVEL (Ioannidis et al., <xref ref-type="bibr" rid="B79">2016</xref>) and VEST3 (Carter et al., <xref ref-type="bibr" rid="B20">2013a</xref>), had the best performance in prediction. However, comparative results should be often interpreted casually since the evaluation of these tools can be hindered by the problem of circularity (Grimm et al., <xref ref-type="bibr" rid="B61">2015</xref>), such as different variants from the same protein occurring both in the datasets used for training and for evaluation. Nevertheless, these predictors are limited to estimate the impacts of SNVs on coding regions. Other computational tools, such as CADD (Kircher et al., <xref ref-type="bibr" rid="B91">2014</xref>), LINSIGHT (Huang et al., <xref ref-type="bibr" rid="B76">2017</xref>), FATHMM (Shihab et al., <xref ref-type="bibr" rid="B167">2015</xref>), etc. have shown certain but limited power in predicting consequences of non-coding variants. Some have developed integrative tools that incorporate several of these algorithms. For example, dnNSFP (Liu et al., <xref ref-type="bibr" rid="B112">2016b</xref>) integrated various computation tools such as SIFT (Ng and Henikoff, <xref ref-type="bibr" rid="B129">2003</xref>), PolyPhen-2 (Adzhubei et al., <xref ref-type="bibr" rid="B2">2010</xref>), and CADD (Kircher et al., <xref ref-type="bibr" rid="B91">2014</xref>), and was developed to be a one-stop database for variant functional predictions and annotations. ANNOVAR (Wang et al., <xref ref-type="bibr" rid="B202">2010</xref>) is another comprehensive annotation tool, which incorporates functional deleteriousness prediction scores from the dbNSFP, variants reported in the ClinVar database, variants reported in dbSNP, etc. These tools intend to interpret SNVs and indels through evaluating their functional impacts on genes, reporting all functional relevance scores from different computational tools, assessing conservation levels of the impacted region, and interrogating the position variability frequency in databases such as 1000 Genomes Project (Gibbs et al., <xref ref-type="bibr" rid="B51">2015</xref>), dbSNP (Sherry et al., <xref ref-type="bibr" rid="B166">2001</xref>), and ExAC (Lek et al., <xref ref-type="bibr" rid="B104">2016</xref>). Since their development, both dnNSFP and ANNOVAR have become popular and widely used variants annotation applications.</p>
<p>Furthermore, applying neural networks (LeCun et al., <xref ref-type="bibr" rid="B102">2015</xref>; Salakhutdinov, <xref ref-type="bibr" rid="B156">2015</xref>) in annotating genomics information by sequences has become prevalent in recent years and indicates the start of the deep learning era for computational biology (Jones et al., <xref ref-type="bibr" rid="B86">2017</xref>). Several WES studies have reported some small sets of DNMs hitting the non-coding regions of the genes along with exonic DNMs (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>), which would require additional interpretations. Two recent methods, DeepSEA (Zhou and Troyanskaya, <xref ref-type="bibr" rid="B220">2015</xref>) and DeepBind (Alipanahi et al., <xref ref-type="bibr" rid="B3">2015</xref>), are great examples of applying the deep learning to model the sequence specificity in various level, particularly on variants hitting at non-coding regions. DeepSEA reached at the single nucleotide resolution to predict transcription factor binding and DNAse sensitivity. DeepBind can forecast the sequence specificity of DNA/RNA- protein binding. Their performance is found to be better than any existing conventional method for predicting non-coding variants consequences. DeepSEA predicts chromatin effects of sequence variations with single-nucleotide sensitivity, by directly learning a regulatory sequence code from large-scale chromatin-profiling data, including transcription factors binding, DNase I sensitivity and histone-mark profiles. DeepBind interrogates the sequence variants by integrating experimental data with a deep convolutional neural network to indicate how variations affect binding within a specific sequence. Compared to DeepSEA, DeepBind analyzes the binding affinity between proteins and DNA/RNA and determines whether mutations could disrupt cellular processes. Overall, the successful implementation of both DeepSEA and DeepBind methods undoubtedly illustrates the advances in non-coding mutations effect annotations.</p>
<p>Also, approximately 10% of disease-causing mutations are mutations within splice site sequences at the intron-exon junctions (Krawczak et al., <xref ref-type="bibr" rid="B96">2007</xref>). Thus, splice-site mutations have been generally considered deleterious (Daguenet et al., <xref ref-type="bibr" rid="B29">2015</xref>). Several computational tools, such as Human Splicing Finder (HSF) (Desmet et al., <xref ref-type="bibr" rid="B36">2009</xref>), GeneSplicer (Pertea et al., <xref ref-type="bibr" rid="B144">2001</xref>), MaxEntScan (<ext-link ext-link-type="uri" xlink:href="http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html">http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html</ext-link>), NNSplice (Reese et al., <xref ref-type="bibr" rid="B150">1997</xref>), and MutPred Splice (Mort et al., <xref ref-type="bibr" rid="B126">2014</xref>), have been developed to interpret splice-site mutations and discriminate pathogenic and tolerated ones. One of the most widely used tools, HSF (Desmet et al., <xref ref-type="bibr" rid="B36">2009</xref>), contains more than 10 algorithms including position weight matrices (PWM), maximum entropy principle, and motif comparison method, to identify splicing motifs across the imputed human sequence. It evaluates the disrupted prediction of the natural discovered splice sites. MutPred Splice, more recent developed machine learning-based (random forest) prediction tool with 21 features, targets substitutions that disrupt pre-mRNA splicing (Mort et al., <xref ref-type="bibr" rid="B126">2014</xref>). A survey of the <italic>in silico</italic> tools that predict potential consequences of splicing mutations has been carried out by Jian et al. (<xref ref-type="bibr" rid="B83">2014</xref>).</p>
<p>Furthermore, some researchers have developed tools to investigate the effects of mutations from their protein structures using the resolved or predicted protein structures, and the protein-protein interaction (PPI) information. For example, Meyer et al. (<xref ref-type="bibr" rid="B119">2018</xref>) developed Interactome INSIDER (INtegrated Structural Interactome and genomic Data browsER), which is a structurally resolved, multi-scale, proteome-wide human interactome allowing to explore human disease mutations functionally. This useful network enables users to analyze disease mutations from databases or from their studies to identify enrichments in protein interaction domains, residues, and atomic 3D clustering in protein interfaces.</p>
<p>In conclusion, when combining computational annotation tools of different purposes, researchers can thoroughly annotate the detected mutations with comprehensive genetic information and ensure having the first step toward a global interrogation of the variant effects (<xref ref-type="fig" rid="F1">Figure 1B</xref>). A proper prioritization of the variants to detect the one with functional effect is therefore crucial to translate the basic research into the clinical intervention for patients' personalized medicine treatment.</p>
</sec>
<sec>
<title>Integrating Inherited and Common Variants to Interpret Rare Genetic Variation From Exome Studies</title>
<p>One of the most popular ways to interpret exome data is to analyze DNMs directly. However, only ~1 to 3 <italic>de novo</italic> events are usually identified in exonic regions in every individual (Iossifov et al., <xref ref-type="bibr" rid="B81">2014</xref>; Turner et al., <xref ref-type="bibr" rid="B190">2016</xref>; Yuen et al., <xref ref-type="bibr" rid="B217">2016</xref>) and there are a plethora of inherited variants also detected by trio WES that might contribute to the disease etiology. One way to gain a more systematic view of variants effects is to combine the <italic>de novo</italic> and the inherited variants effectively. For this purpose, He et al. (<xref ref-type="bibr" rid="B70">2013</xref>) developed a statistical method, later improved by Sanders et al. (<xref ref-type="bibr" rid="B158">2015</xref>), the Transmission and <italic>De novo</italic> Association Analysis (TADA), which identifies disease risk genes by combining <italic>de novo</italic> and transmitted SNVs and small indels, with case-control variants data from the same samples to provide a unified statistical quantification of disease association. TADA weights multiple types of variaions differently, e.g., a LoF mutation weights more than a missense mutation, which in turn weights more than a transmitted LoF mutation. By combining <italic>de novo</italic> and transmitted variants in its analysis, TADA (He et al., <xref ref-type="bibr" rid="B70">2013</xref>; Sanders et al., <xref ref-type="bibr" rid="B158">2015</xref>) assumes that candidate genes for neuropsychiatric disorders would give different types of risks to the disease. Some variants may be causative, while others may be transmitted and play roles as contributors or modifiers. Therefore, by including the information on the inherited variants, one may be able to discover pathogenic genes in cases when DNM information is insufficient. TADA has already been successfully applied in neuropsychiatric disorder studies, such as ASD (He et al., <xref ref-type="bibr" rid="B70">2013</xref>; Sanders et al., <xref ref-type="bibr" rid="B158">2015</xref>; Werling et al., <xref ref-type="bibr" rid="B207">2018</xref>), SCZ (Takata et al., <xref ref-type="bibr" rid="B182">2014</xref>; Nguyen et al., <xref ref-type="bibr" rid="B130">2017</xref>), and can easily be applied to other datasets as well.</p>
<p>Besides assessing whether a particular variant is associated with disease by comparing the observed frequency in cases vs. controls, it is also important to consider the mutation rate of the gene carrying DNMs. Samocha et al. (<xref ref-type="bibr" rid="B157">2014</xref>) introduced a statistical metric measure to assess expected vs. observed DNMs by estimating the statistical likelihood of a DNM occurring spontaneously in a gene. The model first calculates the mutation rate for a gene from SNPs in non-coding regions of the genome for all possible trinucleotide to trinucleotide changes, such as AGA evolving to ATA, ACA, or AAA. Then sequence context is considered to determine separate rates for each base changing to each other base for all bases across from the coding region and the annotated conserved splice site. By applying this approach, the consequence of various types of mutation change (e.g., loss-of-function, missense, synonymous) on the corresponding amino acid coded for is determined, and the probabilities for each outcome occurring in a gene are evaluated to create a likelihood per gene for each type of DNMs. With this, Samocha et al. was able to identify 1,003 genes that are estimated to be significantly intolerant to variations that change the coding sequence of the gene (Samocha et al., <xref ref-type="bibr" rid="B157">2014</xref>).</p>
<p>Another approach to consider mutation rate of the risk gene carrying DNMs is by incorporating the imputation-based rare variant burden test using a follow-up cohort after the DNM identification. It has been shown that the discovery of a rare variant near a common variant might be particularly informative to clarify which of the candidate gene is pathogenic (Teslovich et al., <xref ref-type="bibr" rid="B185">2010</xref>; Voight et al., <xref ref-type="bibr" rid="B201">2010</xref>; Momozawa et al., <xref ref-type="bibr" rid="B124">2011</xref>). Thus, applying the common variant burden test imputed to the reference SNP panel on genes carrying DNMs can be an alternative approach to assess the pathogenicity of the variants. Recently, Browning et al. (Pullabhatla et al., <xref ref-type="bibr" rid="B148">2018</xref>) has implemented a DNM study pipeline that includes variant discovery and burden test with imputation to reference SNP panel across coding regions of genes. In addition to discover confident candidates, it shows the SNP with genotype imputation mainly implemented for GWAS still can be a powerful supplementary annotation to the rare variant analysis.</p>
</sec>
<sec>
<title>Network Approaches to Enhance Understanding of the Disease Functional Pathways</title>
<p>With various forms of large-scale genetic association studies, researchers have detected hundreds to thousands of genetic <italic>loci</italic> that are involved in NDP disorder risk (Gratten et al., <xref ref-type="bibr" rid="B60">2014</xref>). As a consequence, many works adopting rigorous data-driven integrative network methods have been carried out to understand how all these genetic variants contribute to the disease etiology of NDP disorders (Geschwind and Konopka, <xref ref-type="bibr" rid="B50">2009</xref>; Parikshak et al., <xref ref-type="bibr" rid="B138">2015</xref>). The network approaches use the experimentally measured or predicted relationships between genes to link them to each other and provide an organized structural system for placing each gene in the context of its molecular framework. Networks usually model genome-wide data by displaying molecular entities, such as genes carrying DNMs from WES or protein products of the impacted genes, as nodes and the associations between nodes as network edges. Edges can be the statistical similarities between genes, such as brain-expression correlations, or physical interactions between proteins. Edges define the network connectivity and consequently define the hierarchical structures of the nodes, which can usually be organized into a relatively small group of highly interconnected modules expected to represent functional module entities. Both the inter-modular connectivity and intra-modular connectivity are used to reflect the important biological relationships: the first one reveals a higher-order organization of the network and the latter one can identify which genes are biological modulators within modules. They are often employed in the integrative analysis pipeline to identify causal functional pathways and molecular drivers of cellular and brain-wide pathology in disorders (Carter et al., <xref ref-type="bibr" rid="B21">2013b</xref>; Furlong, <xref ref-type="bibr" rid="B46">2013</xref>; Mitra et al., <xref ref-type="bibr" rid="B123">2013</xref>).</p>
<p>Here, we describe two main network approaches (<xref ref-type="fig" rid="F1">Figure 1C</xref>), co-expression and protein-protein interaction (PPI), to illustrate the network analysis of genes in NDP disorders (Gilman et al., <xref ref-type="bibr" rid="B53">2012</xref>; O'Roak et al., <xref ref-type="bibr" rid="B136">2012b</xref>; Gulsuner et al., <xref ref-type="bibr" rid="B64">2013</xref>; Parikshak et al., <xref ref-type="bibr" rid="B139">2013</xref>; Willsey et al., <xref ref-type="bibr" rid="B210">2013</xref>). Gene expression has been widely used to investigate biological and functional relationships between human genes. The co-expression analysis was mainly designed to explore shared expression patterns in data from different experiments, tissues, or species (Stuart et al., <xref ref-type="bibr" rid="B177">2003</xref>; Zhang and Horvath, <xref ref-type="bibr" rid="B219">2005</xref>; Prifti et al., <xref ref-type="bibr" rid="B147">2010</xref>). As results, the co-expression network utilizes the gene expression pattern correlation between genes to generate links between nodes to relate disease genes to each other (e.g., DNM genes) for the systems-level analysis, followed by the module discovery to identify topologically highly connected network modules (Cline et al., <xref ref-type="bibr" rid="B25">2007</xref>; Amar et al., <xref ref-type="bibr" rid="B4">2013</xref>; van Dam et al., <xref ref-type="bibr" rid="B193">2017</xref>). Next, one can perform the module functional enrichment analysis to identify possible disease or brain-related pathways by using pathway databases such as the Gene Ontology (GO) (Ashburner et al., <xref ref-type="bibr" rid="B7">2000</xref>), the Kyoto Encyclopedia of Genes, and Genome Elements (KEGG) (Kanehisa and Goto, <xref ref-type="bibr" rid="B87">2000</xref>), with the aim to facilitate the discovery of potential therapeutic targets or biomarkers. The multiple publications in different disorders have demonstrated the effectiveness of this method in identifying disease related pathways, such ASD (Parikshak et al., <xref ref-type="bibr" rid="B139">2013</xref>, <xref ref-type="bibr" rid="B140">2016</xref>; Gupta et al., <xref ref-type="bibr" rid="B65">2014</xref>) or SCZ (Fromer et al., <xref ref-type="bibr" rid="B45">2014</xref>). For instance, Fromer et al. (<xref ref-type="bibr" rid="B45">2014</xref>) has applied the co-expression network approach on the set of genes hit by DNMs in patients and identified co-expression modules related to neuronal functions, including axon guidance, postsynaptic membrane, which supported the significance of the findings. Also, co-expression network analysis has also been successfully applied in cross-psychiatric-disorder studies which analyzed collective DNMs to investigate the genetic convergence among psychiatric disorders (Shohat et al., <xref ref-type="bibr" rid="B168">2017</xref>; Gandal et al., <xref ref-type="bibr" rid="B47">2018</xref>). For example, Gandal et al. found an astrocyte-related module significantly up-regulated in ASD, BD, and SCZ, and enriched for glial cell differentiation and fatty-acid metabolism pathways.</p>
<p>Another important characteristic of the biological systems is that proteins function in pairs and groups by interacting with other molecules (e.g., DNA, RNA) to regulate metabolic and signaling pathways, cellular processes, even organismal systems. As a result, PPI integrative network methods can be used to relate disease risk genes (e.g., DNM genes) to each other and their topological locations within the network modules in order to identify the potential diseases pathways. An essential organized network can be constructed by using experimentally measured or predicted associations to place each gene carrying DNM in the context of its molecular system (Geschwind and Konopka, <xref ref-type="bibr" rid="B50">2009</xref>). Thus, PPI networks have emerged as a powerful resource, together with other information, to complement genetic data such as DNMs to elucidate causal molecular drivers of cellular, circuit level, and brain-wide alterations in pathology (Bergholdt et al., <xref ref-type="bibr" rid="B14">2007</xref>; Lage et al., <xref ref-type="bibr" rid="B99">2008</xref>; Neale et al., <xref ref-type="bibr" rid="B128">2012</xref>; O'Roak et al., <xref ref-type="bibr" rid="B136">2012b</xref>) (<xref ref-type="fig" rid="F1">Figure 1D</xref>). For example, DAPPLE (Rossin et al., <xref ref-type="bibr" rid="B155">2011</xref>) was developed to search for the significant physical connectivity among proteins encoded by disease risk genes according to PPIs reported in the literature. Neale et al. (<xref ref-type="bibr" rid="B128">2012</xref>) and Xu et al. (<xref ref-type="bibr" rid="B212">2012</xref>) have applied DAPPLE to determine whether there is an over-represented of PPIs among the genes hit by a functional <italic>de novo</italic> event in their results from trio WES studies in NDP disorders. The fact that different types of mutations, such as <italic>de novo</italic> SNVs and <italic>de novo</italic> CNVs, can be discovered from genome-scale studies, a network-based analysis that considers all types of mutations can be a powerful strategy for system-level understanding of the disease. To this end, NETBAG+ (Gilman et al., <xref ref-type="bibr" rid="B53">2012</xref>), has been developed to consider multiple lines of mutational data from diseases, such as <italic>de novo</italic> SNVs, <italic>de novo</italic> CNVs, and SNP data from GWAS studies, and performed the PPI network-based integrative analysis to investigate the convergence of heterogeneous neuropsychiatric genetic variation on a functional system level.</p>
<p>In addition, some studies have combined PPIs and gene expressions to perform an integrative network analysis to better elucidate the underlining genetic basis of sets of interested genes, such as the significance of the interconnection between detected genes hits by DNMs and the overall impact of the variants in NDP disorders and have achieved successful results (Gulsuner et al., <xref ref-type="bibr" rid="B64">2013</xref>; Hamdan et al., <xref ref-type="bibr" rid="B68">2014</xref>; O'Roak et al., <xref ref-type="bibr" rid="B134">2014</xref>; Lin et al., <xref ref-type="bibr" rid="B110">2015</xref>). <xref ref-type="supplementary-material" rid="SM3">Supplementary Table 3</xref> shows the characteristics and differences between different network-based methods.</p>
</sec>
</sec>
<sec id="s4">
<title>Progress and limitations in translating NGS from research to clinical implementation</title>
<p>Traditionally, diagnosing individuals with neuropsychiatric disorders is a very long and tedious process, and includes a large set of clinical assessments, such as dysmorphology evaluation, development monitoring, intellectual function assessment. With increasing acknowledgment of a strong genetic influence to the psychiatric disorders, especially in ASD and ID/DD, with subset of cases with an underlying genetic syndrome, clinical laboratory testing to find genomic variants in risk genes is now an important part of the diagnostic work. Genomic risk variants scanning would be considered when the clinical symptoms and test results suggest a suspected diagnose. This strategy resulted in a diagnosis rate from 5 to 50% in cases (Battaglia et al., <xref ref-type="bibr" rid="B12">1999</xref>; Battaglia and Carey, <xref ref-type="bibr" rid="B13">2003</xref>; Challman et al., <xref ref-type="bibr" rid="B22">2003</xref>; Moog, <xref ref-type="bibr" rid="B125">2005</xref>; van Karnebeek et al., <xref ref-type="bibr" rid="B194">2005</xref>). However, clinicians often tussle with the diseases' phenotypic diversity and are challenged to select a proper genetic testing for complex cases.</p>
<sec>
<title>Current NGS Gene-Panels Commercially Available for Clinical Genetic Testing</title>
<p>Currently, the recommended laboratory genetic test for disorders, such as ASD and ID/DD, is the chromosomal microarray (Miller et al., <xref ref-type="bibr" rid="B121">2010</xref>), targeting deleted and duplicated segments of DNA (CNVs) that only account for 5–25% of cases (Tammimies et al., <xref ref-type="bibr" rid="B183">2015</xref>). In contrast, the NGS technology provides in-depth view of genomic landscape and can be used to target a selection of genes of interest by targeted gene panels, the entire coding portions of all genes by WES, or the entire genome by WGS to gain a comprehensive map of the genomic variants. Compared with the sequential testing of multiple genes historically, NGS allows the rapid sequencing of various genes simultaneously at a lower cost and is expected to improve clinical diagnosis of disorders and patients' management. NGS has proven indispensable to discover new neuropsychiatric disorder risk genes. In addition, integrative analyses of NGS data have been fruitful in illuminating the underlining genetic basis of disease etiology. It has also been commercially available as a second-tier genetic test and has demonstrated to be a powerful supplementary technique for both risk gene discovery and clinical application in disease diagnosis (<xref ref-type="fig" rid="F1">Figure 1F</xref>) (Bainbridge et al., <xref ref-type="bibr" rid="B8">2011</xref>; Kingsmore et al., <xref ref-type="bibr" rid="B90">2011</xref>; Boycott et al., <xref ref-type="bibr" rid="B17">2013</xref>).</p>
<p>As result, a number of NGS-based clinical testing panels have been developed and are available as NGS-based Laboratory Developed Tests (LDTs) for a set of neurodevelopmental disorders, such as Fragile X syndrome, Prader-Willi syndrome, and Angelman syndrome. These panels are useful to target a limited number of well-demonstrated causative genes involved in these disorders. However, for many psychiatric disorders with complex genetic basis, the number of genes involved is very large and the degree of confidence of the implication of these genes in disorders is in constant re-evaluation. Currently, most of available commercial genetic testing panels are for two types of complex psychiatric diseases: autism and intellectual disability. Hoang et al. (<xref ref-type="bibr" rid="B73">2018</xref>) has performed a comprehensive survey in the clinical sequencing panel test for ASD and found a significant heterogeneity among different laboratories with respect to the tests they offer. Their most striking finding was the number of tested genes on panels used for ASD vary from 11 to 2,562, with little overlap. Here, we performed a similar comparison on NGS-based clinical testing panel used for ID/DD and looked at the number of genes included in panels. We also found a large difference between different panels and included genes can range from 13 to 2,562 (<xref ref-type="table" rid="T2">Table 2</xref>), which is not surprised since the genetic predisposition may be different in almost every individual in these complex psychiatric disorders due to their heterogeneous nature. This shows that it is still a challenging task to reach consensus gene lists for testing panels in complex psychiatric disorders currently; and indicates that WES might be a better alternative for genetic testing when casual variants are not known since it targets all coding regions of the genome without biases in the gene pre-selection. Thus, targeted gene panels would be ideal for analyzing specific mutations or genes that have suspected associations with disease, while WES could be a better choice when one is uncertain what genes need to be tested.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Clinical intellectual disability gene sequencing panels available as of January 2019.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Laboratory company</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold># of genes included</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Test name</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ambry Genetics</td>
<td align="center" colspan="1" rowspan="1" valign="top">140</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intellectual Disability (IDNext)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ApolloGen</td>
<td align="center" colspan="1" rowspan="1" valign="top">114</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-Linked Intellectual Disability Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Blueprint Genetics</td>
<td align="center" colspan="1" rowspan="1" valign="top">99</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-linked Intellectual Disability Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Centogene</td>
<td align="center" colspan="1" rowspan="1" valign="top">178</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-linked Intellectual Disability Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CGC Genetics</td>
<td align="center" colspan="1" rowspan="1" valign="top">89</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intellectual Disability, X-linked NGS panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DDC Clinic</td>
<td align="center" colspan="1" rowspan="1" valign="top">13</td>
<td align="left" colspan="1" rowspan="1" valign="top">Overgrowth and Intellectual Disability NGS Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">EGL Genetics</td>
<td align="center" colspan="1" rowspan="1" valign="top">92</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-linked Intellectual Disability: Sequencing Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fulgent Genetics</td>
<td align="center" colspan="1" rowspan="1" valign="top">495</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intellectual Disability NGS Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gene DX</td>
<td align="center" colspan="1" rowspan="1" valign="top">2562</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism/ID Xpanded Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GGC (Greenwood Genetic Center)</td>
<td align="center" colspan="1" rowspan="1" valign="top">114</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-Linked Intellectual Disability (XLID) Sequencing Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Human Genetics Laboratory (University of Nebraska Medical Center)</td>
<td align="center" colspan="1" rowspan="1" valign="top">117</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism / Intellectual Disability / Multiple Anomalies Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Humangenetik</td>
<td align="center" colspan="1" rowspan="1" valign="top">867</td>
<td align="left" colspan="1" rowspan="1" valign="top">Complete Panel (#017): Intellectual Disability</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MGZ (Medical Genetics Center)</td>
<td align="center" colspan="1" rowspan="1" valign="top">115</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-Linked Intellectual Disability Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MNG Laboratories</td>
<td align="center" colspan="1" rowspan="1" valign="top">894</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comprehensive Intellectual Disability/Autism + MtDNA Panel</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Prevention Genetics</td>
<td align="center" colspan="1" rowspan="1" valign="top">256</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-Linked Intellectual Disability Sequencing Panel with CNV Detection</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Transgenomic</td>
<td align="center" colspan="1" rowspan="1" valign="top">119</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism and Intellectual Disability NGS Panel</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>It is worth mentioning that WGS starts to show its advantage over WES, such as providing a more uniformed coverage, able to identify more variants covering both coding, and non-coding regions of the genome (Wilfert et al., <xref ref-type="bibr" rid="B208">2017</xref>). It is important to extend the interrogation to non-coding variants as these represent the majority of DNMs per genome. A relevant role in neurodevelopmental disorders of these regions such as the non-coding RNAs has already been established (Wanke et al., <xref ref-type="bibr" rid="B204">2018</xref>). Although the current sequencing cost of WGS is still at least three times higher than WES per sample using NovaSeq technology as of January 2019 (<xref ref-type="supplementary-material" rid="SM4">Supplementary Table 4</xref>; <ext-link ext-link-type="uri" xlink:href="https://genohub.com/">https://genohub.com/</ext-link>), the implementation of WGS has the potential to ultimately replace WES both in research and clinical settings with a decreasing cost in whole genome sequencing and a rapid maturation of its analytical platforms.</p>
</sec>
<sec>
<title>Translation of WES for Diagnostic of Neuropsychiatric Disorders From Research to Clinical Practice</title>
<p>As described above, an alternative strategy is needed that could take advantage of the recent advance of large-scale sequencing techniques and yield faster and higher diagnostic rates. The unbiased nature of WES can reduce the impact of disease variability on genetic testing strategies by equally weighing all genes and making assessments for all identified variants simultaneously in one clinical context (Shashi et al., <xref ref-type="bibr" rid="B164">2014</xref>; Lencz and Malhotra, <xref ref-type="bibr" rid="B106">2015</xref>). Hence, the true exonic phenotypic variability of genetic disorders can be assessed by WES. There are cases in the literature of pathogenic variants identified in patients that would never have been considered for a genetic testing based on their phenotypes (Fogel et al., <xref ref-type="bibr" rid="B42">2014</xref>; Guerreiro et al., <xref ref-type="bibr" rid="B62">2014</xref>; Lu et al., <xref ref-type="bibr" rid="B114">2014</xref>). This also underlines a vital role for clinical input in bioinformatics analysis when estimating the likely contributions of new genetic variations in disorders of a particular patient. Several large studies have already demonstrated a diagnostic yield of 25–45% for clinical WES (Dixon-Salazar et al., <xref ref-type="bibr" rid="B37">2012</xref>; Yang et al., <xref ref-type="bibr" rid="B214">2013</xref>, <xref ref-type="bibr" rid="B215">2014</xref>; Lee et al., <xref ref-type="bibr" rid="B103">2014</xref>; Stark et al., <xref ref-type="bibr" rid="B173">2016</xref>). Moreover, Stark et al. (<xref ref-type="bibr" rid="B173">2016</xref>) found that singleton WES as a first-tier screening method, outperforms the standard care in infants with suspected Mendelian disorders (57.5 vs. 13.75% diagnosis rate).</p>
<p>Several large diagnostic sequencing laboratories/institutions, such as Ambry Genetics Laboratory (Rossi et al., <xref ref-type="bibr" rid="B154">2017</xref>), have published studies on the efficacy of diagnosis in patients with suspected genetic disorders using the exome sequencing. They have shown particularly effective diagnosis rates in patients with neuropsychiatric or neurodevelopmental diseases based on Mendelian traits, as shown in <xref ref-type="table" rid="T3">Table 3</xref>. For instance, in the field of psychiatric disorders of early onsets, such as ASD, the genetic diagnostic yield was almost doubled when WES was used in addition to chromosomal microarrays (Tammimies et al., <xref ref-type="bibr" rid="B183">2015</xref>; Rossi et al., <xref ref-type="bibr" rid="B154">2017</xref>). The implementation of WES in the field of rare pediatric disorders has already shown encouraging success rates, 28–40% when proband-only or trio WES were considered (Wright et al., <xref ref-type="bibr" rid="B211">2018</xref>). Moreover, a pediatric neurology study obtained a higher rate of conclusive diagnoses not exceeding the economic cost supporting the usage of WES as the first-tier diagnostic test (Vissers et al., <xref ref-type="bibr" rid="B200">2017</xref>). Overall, the promising results regarding time and diagnostic rates from these psychiatric studies are genuinely encouraging.</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Rates of diagnosis for psychiatric disorders using clinical exome sequencing.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Study</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Rate of psychiatric diagnosis<xref ref-type="table-fn" rid="TN2"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Rate of <italic>de novo</italic> event</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Global average year</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Yang et al., <xref ref-type="bibr" rid="B214">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">26% (55/213)</td>
<td align="left" colspan="1" rowspan="1" valign="top">47% (29/62)</td>
<td align="left" colspan="1" rowspan="1" valign="top">5–18 years (94 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurologic disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&lt;5 years (124 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurologic disorder and other organ-system disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;18 years (28 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">specific neurologic disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">fetus (4 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">non-neurologic disorder</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Yang et al., <xref ref-type="bibr" rid="B215">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">26% (455/1756)</td>
<td align="left" colspan="1" rowspan="1" valign="top">72% (248/345)</td>
<td align="left" colspan="1" rowspan="1" valign="top">5–18 years (845 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurological disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&lt;5 years (900 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurological plus other organ systems disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;18 years (244 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">specific neurological disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">fetus (11 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">non-neurological disorder</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lee et al., <xref ref-type="bibr" rid="B103">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">26% (175/673)</td>
<td align="left" colspan="1" rowspan="1" valign="top">50% (63/127)</td>
<td align="left" colspan="1" rowspan="1" valign="top">5–18 years (266 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">developmental delay</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">developmental delay and other syndrome</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&lt;5 years (254 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ataxia and related neurological disorders</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">muscular dystrophy and related disorders</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;18 years (294 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">cardiomyopathy and arrhythmia</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">cancer predisposition</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">disorder of sexual development</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Retinal disorders</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Farwell et al., <xref ref-type="bibr" rid="B41">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">31% (99/324)</td>
<td align="left" colspan="1" rowspan="1" valign="top">49% (80/163)</td>
<td align="left" colspan="1" rowspan="1" valign="top">prenatal (2 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">intellectual disability and/or developmental delay</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">0–3 months (12 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">brain MRI positive</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&lt;1 years (36 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">multiple congenital anomalies</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">1–5 years (194 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">seizures/epilepsy</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">5–12 years (117 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">progressive phenotype</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">12–18 years (58 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">ataxia</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">18–40 years (45 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">autism spectrum disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;40 years (36 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">psychiatric abnormality</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tammimies et al., <xref ref-type="bibr" rid="B183">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">3% (8/95)</td>
<td align="left" colspan="1" rowspan="1" valign="top">38% (3/8)</td>
<td align="left" colspan="1" rowspan="1" valign="top">average 4.5 ± 1.7 years</td>
<td align="left" colspan="1" rowspan="1" valign="top">Asperger syndrome</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">autistic disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">pervasive developmental disorder - not otherwise specified</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Wenger et al., <xref ref-type="bibr" rid="B206">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">10% (4/40)</td>
<td align="left" colspan="1" rowspan="1" valign="top">100% (4/4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">2–5 years (10 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurologic abnormality</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">congenital anomalies</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">5–10 years (12 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">metabolic abnormality</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">musculoskeletal abnormality</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&lt;2 years (9 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">cancer</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">gastrointestinal abnormality</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">&gt;10 years (9 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">hearing loss</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">vascular abnormality</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stark et al., <xref ref-type="bibr" rid="B173">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">58% (46/80)</td>
<td align="left" colspan="1" rowspan="1" valign="top">35% (16/46)</td>
<td align="left" colspan="1" rowspan="1" valign="top">0–6 months (37 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">congenital abnormalities and dysmorphic features</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">neurometabolic disorder</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">6–12 months (25 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">skeletal dysplasia</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">eye abnormality</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">12–36 months (18 individuals)</td>
<td align="left" colspan="1" rowspan="1" valign="top">other abnormality (gastrointestinal, renal, immunological)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rossi et al., <xref ref-type="bibr" rid="B154">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">26% (42/163)</td>
<td align="left" colspan="1" rowspan="1" valign="top">62% (26/42)</td>
<td align="left" colspan="1" rowspan="1" valign="top">average 9.0 ± 6.7 years</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurologic abnormality</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Baldridge et al., <xref ref-type="bibr" rid="B9">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">43% (67/155)</td>
<td align="left" colspan="1" rowspan="1" valign="top">51% (34/67)</td>
<td align="left" colspan="1" rowspan="1" valign="top">average 6 years (3 days−33 years)</td>
<td align="left" colspan="1" rowspan="1" valign="top">neurological abnormality</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">multiple congenital anomalies</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">mixed, neurological plus</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">other clinical specifics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Smith et al., <xref ref-type="bibr" rid="B171">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">69% (64/96)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nambot et al., <xref ref-type="bibr" rid="B127">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">15% (24/156)</td>
<td align="left" colspan="1" rowspan="1" valign="top">50% (64/128)</td>
<td align="left" colspan="1" rowspan="1" valign="top">average 10.5 years</td>
<td align="left" colspan="1" rowspan="1" valign="top">congenital anomaly without intellectual disability</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">neuromuscular disorders</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">neurodevelopmental disorders</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Vissers et al., <xref ref-type="bibr" rid="B200">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">29% (44/150)</td>
<td align="left" colspan="1" rowspan="1" valign="top">30% (13/44)</td>
<td align="left" colspan="1" rowspan="1" valign="top">average 5.58 years (5 months−18 years)</td>
<td align="left" colspan="1" rowspan="1" valign="top">complex neurological disorders</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN2">
<label>*</label>
<p><italic>Rate of psychiatric diagnosis refers to the percent of patients for whom were given a positive genetic diagnosis in this study; Overall diagnostic rate (all presentations) refers to the percent of patients for whom were given a positive genetic diagnosis in this and previous study; Rate of de novo event refers to the percent of events that patients carrying DNM(s) were diagnosed as positive result; Sex ratio and Global average year declaim the sex and age contribution of patient samples</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Challenges of NGS Application in NDP Disorders Clinical Diagnosis</title>
<p>The step toward the implementation of NGS technologies in large-scale clinical practice is still limited and variable across countries. The evaluation of the cost-effectiveness and management of these test remains extremely difficult (Payne et al., <xref ref-type="bibr" rid="B143">2018</xref>). The application of WES in clinical practice as a diagnostic tool for neuropsychiatric disorders is challenging, overall. It is well-known that NDP disorders have strong genetic components (Gandal et al., <xref ref-type="bibr" rid="B48">2016</xref>), hold a high degree of genetic and clinical heterogeneity, and present with variable expressivity and penetrance. Also, it has been demonstrated that diverse NDP disorders share genetic etiology (Cross-Disorder Group of the Psychiatric Genomics Consortium et al., <xref ref-type="bibr" rid="B27">2013</xref>). Hence, using WES is a promising approach to elucidate the genetic causes of NDP disorders, however, multiple concerns remain to be addressed.</p>
<p>A major concern for WES, in general, is the interpretation of the results. The first challenge is how to elucidate the pathogenic effects of the identified variant(s). Multiple prediction tools and algorithms have been developed (section Interpreting Rare Genetic Variants From Exome Studies), but no gold standard interpretation guide could undoubtedly explain the causality or benignity of variants. Enormous databases of large populations' sequencing data are available, such as 1000 Genome Project (Gibbs et al., <xref ref-type="bibr" rid="B51">2015</xref>) or ExAC (Lek et al., <xref ref-type="bibr" rid="B104">2016</xref>), to filter out variants that are common in the population and to rank the mutation tolerance of genes. However, large datasets of multiple populations still need to be compiled. The American College of Medical Genetics and Genomics (ACMG) published guidelines that have helped to manage clinical molecular genetic cases (Richards et al., <xref ref-type="bibr" rid="B151">2015</xref>; Nykamp et al., <xref ref-type="bibr" rid="B132">2017</xref>; Strovel et al., <xref ref-type="bibr" rid="B176">2017</xref>). In particular, recommendations on reporting incidental findings are essential in the clinical application of global genomic approaches.</p>
<p>Our current knowledge of NDP disorders' biological mechanisms is still limited, and the contribution of the majority of the genes in the genome to these phenotypes remains unclear. Some disease-related gene databases as ASD genes database SFARI (Abrahams et al., <xref ref-type="bibr" rid="B1">2013</xref>) have introduced a scoring parameter that ranks from high confidence to hypothesized but untested, which is extremely useful to evaluate the association of a variant within these genes to the neuropsychiatric phenotype. Besides, the contributing effect of susceptibility or modifier genes remains to be systematically quantified. Therefore, advancements in knowledge moving toward these types of gene and disease potential associations will be an excellent way to help the variant classification.</p>
<p>WES <italic>per se</italic> presents some technical limitations. For example, WES has a low efficiency in detecting microsatellite expansions, which nowadays, can only be overcome using alternative techniques such as PCR or Southern blot. WES also presents a limited power to detect small CNVs and mosaic events, which require a much deeper read coverage than the regular clinical WES. Another limitation in neuropsychiatric disorders is the types of tissues studies, as brain tissues from the living individuals are not possible to obtain, the detection of brain-specific mosaic events particular to these tissues would be missed. Therefore, the complete picture of the genomic alterations of neuropsychiatric disorders will be difficult to achieve.</p>
<p>Elucidating the complex nature of the underlying genetics of neuropsychiatric disorders will ultimately require sophisticated mathematical models that include a large number of parameters extracted from genomic, phenotypic information, pharmacogenomics interactions, and environmental factors, among others. These complex approaches will only be reached when systematic high throughput multi-omic studies are applied to each patient, and consensus annotation terms and pipelines are used (precision medicine). Compared to difficulty in characterizing the underlying genetics of neuropsychiatric disorders, some efforts toward regulating the phenotypic terms encountered in human diseases have been made. Human Phenotype Ontology (Köhler et al., <xref ref-type="bibr" rid="B93">2017</xref>) initiative and gene-associated phenotypes database as Online Mendelian Inheritance in Man® (OMIM®) are still struggling to build a standardized vocabulary of phenotypic abnormalities and its likely genetic causes. Furthermore, recently developed platforms of phenotype-genotype relationship sharing, by The Matchmaker Exchange (Philippakis et al., <xref ref-type="bibr" rid="B145">2015</xref>), are already connecting worldwide clinicians and researchers with the aim to link clinical and genetic information and to identify novel genes causative of rare disease phenotypes.</p>
<p>Finally, the extended consequences of reaching a genetic diagnosis in neuropsychiatric disorders are especially relevant for family members and caretakers. Besides a better selection of therapeutic strategies, more accurate prognosis, appropriate support, and surveillance, risk estimation and counseling are essential for the future familial organization and reproductive planning not only for parents but also for other siblings. The application of WES requires multidisciplinary teams with a core of medical geneticist and genetic counselors who will help patients to understand the overwhelming information derived from these complex tests and ensure they make informed decisions (Paneque et al., <xref ref-type="bibr" rid="B137">2017</xref>).</p>
</sec>
</sec>
<sec id="s5">
<title>Limitation of the Current Review</title>
<p>We acknowledge that there are many areas of WES in neuropsychiatric disorders that were not deeply addressed within this review, such as certain statistical parameters like effect size, and comparison between different statistical methods used by different tools, since they could not be easily summarized and compared, as not all studies used the same criteria. In writing this review, we relied primarily on the DNM data from denovo-db (Turner et al., <xref ref-type="bibr" rid="B191">2017</xref>), which collects DNMs from large cohort studies from the past 10 years and might be missing data from some small cohort studies. In addition, the impact of DNMs in disease etiology might vary in different disorders, it exerts a large contribution for ASD and ID/DD and have smaller contributions from other disorders, such as BD and OCD, which might be because of a lack of studies or data. Therefore, how the exome case-control study might be used as a complementary strategy to the trio-based study for those disorders can be an excellent topic for a future review.</p>
<p>The current review is intended to serve as a broad summary, analysis, and application of neurodevelopmental and psychiatric DNVs from WES. We believe that future studies and reviews that approach genomic variants from a different angle with different NGS technologies, such as WGS or by focusing on the finer statistical details, even going so far as to scrutinize clinical data from individuals, and to link them to the variants for the interpretation, would lead to interesting and important findings.</p>
</sec>
<sec id="s6">
<title>Conclusion and Future Directions</title>
<p>Despite many complications and challenges associated with NDP disorders, increasing implications of <italic>de novo</italic> event's contribute to the disease etiology, together with downstream functional analyses to explore the disrupted biological process by these <italic>de novo</italic> events, indicate the advent of the application of WES in potential treatments. Moreover, a large number of ASD drugs currently in the pipeline (Sung et al., <xref ref-type="bibr" rid="B181">2014</xref>) keeps us optimistic about the future. The application of WES in clinical practice has the potential to generate an extraordinarily large dataset for multiple disorders. Obtaining large cohorts in research studies, particularly for rare neuropsychiatric diseases, is very difficult or even impossible. As a consequence, it is imperative that clinicians and researchers find a comprehensive protocol to share the genetic information and perform powerful genetic and genomic studies of diseases, always under strict data sharing protocols preserving patients' confidentiality. In the foreseeable future, we will see the development of well-established and tested systematic computational pipelines to integrate genetic and genomic data with expression, interaction and other data that will ultimately facilitate the implementation of NGS into the clinical practice.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>GL designed the concept. GL and WW researched the data. GL, WW, and RC all contributed to the content discussion, writing, and editing of the manuscript.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by grants from the National Key R&amp;D Program of China (2017YFC0909200), the National Natural Science Foundation of China (No. 81671328), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (No. 1610000043) and the Innovation Research Plan supported by Shanghai Municipal Education Commission (ZXWF082101).</p>
</fn>
</fn-group>
<sec id="s8" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2019.00258/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2019.00258/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Table_1.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM2">
<media xlink:href="Table_2.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM3">
<media xlink:href="Table_3.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM4">
<media xlink:href="Table_4.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Arking</surname><given-names>D. E.</given-names></name><name><surname>Campbell</surname><given-names>D. B.</given-names></name><name><surname>Mefford</surname><given-names>H. C.</given-names></name><name><surname>Morrow</surname><given-names>E. M.</given-names></name><name><surname>Weiss</surname><given-names>L. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs)</article-title>. <source/>Mol. Autism
<volume>4</volume>:<fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-4-36</pub-id><pub-id pub-id-type="pmid">24090431</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adzhubei</surname><given-names>I. A.</given-names></name><name><surname>Schmidt</surname><given-names>S.</given-names></name><name><surname>Peshkin</surname><given-names>L.</given-names></name><name><surname>Ramensky</surname><given-names>V. E.</given-names></name><name><surname>Gerasimova</surname><given-names>A.</given-names></name><name><surname>Bork</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nat. Methods
<volume>7</volume>, <fpage>248</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id><pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alipanahi</surname><given-names>B.</given-names></name><name><surname>Delong</surname><given-names>A.</given-names></name><name><surname>Weirauch</surname><given-names>M. T.</given-names></name><name><surname>Frey</surname><given-names>B. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning</article-title>. <source/>Nat. Biotechnol.
<volume>33</volume>, <fpage>831</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3300</pub-id><pub-id pub-id-type="pmid">26213851</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amar</surname><given-names>D.</given-names></name><name><surname>Safer</surname><given-names>H.</given-names></name><name><surname>Shamir</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Dissection of regulatory networks that are altered in disease via differential co-expression</article-title>. <source/>PLoS Comput. Biol.
<volume>9</volume>:<fpage>e1002955</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1002955</pub-id><pub-id pub-id-type="pmid">23505361</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antaki</surname><given-names>D.</given-names></name><name><surname>Brandler</surname><given-names>W. M.</given-names></name><name><surname>Sebat</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>SV2: accurate structural variation genotyping and <italic>de novo</italic> mutation detection from whole genomes</article-title>. <source/>Bioinformatics
<volume>34</volume>, <fpage>1774</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx813</pub-id><pub-id pub-id-type="pmid">29300834</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appenzeller</surname><given-names>S.</given-names></name><name><surname>Balling</surname><given-names>R.</given-names></name><name><surname>Barisic</surname><given-names>N.</given-names></name><name><surname>Baulac</surname><given-names>S.</given-names></name><name><surname>Caglayan</surname><given-names>H.</given-names></name><name><surname>Craiu</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title><italic>De novo</italic> mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies</article-title>. <source/>Am. J. Hum. Genet.
<volume>95</volume>, <fpage>360</fpage>–<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.08.013</pub-id><pub-id pub-id-type="pmid">25262651</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M.</given-names></name><name><surname>Ball</surname><given-names>C. A.</given-names></name><name><surname>Blake</surname><given-names>J. A.</given-names></name><name><surname>Botstein</surname><given-names>D.</given-names></name><name><surname>Butler</surname><given-names>H.</given-names></name><name><surname>Cherry</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Gene ontology: tool for the unification of biology</article-title>. <source/>Nat. Genet.
<volume>25</volume>, <fpage>25</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/75556</pub-id><pub-id pub-id-type="pmid">10802651</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bainbridge</surname><given-names>M. N.</given-names></name><name><surname>Wiszniewski</surname><given-names>W.</given-names></name><name><surname>Murdock</surname><given-names>D. R.</given-names></name><name><surname>Friedman</surname><given-names>J.</given-names></name><name><surname>Gonzaga-Jauregui</surname><given-names>C.</given-names></name><name><surname>Newsham</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Whole-Genome sequencing for optimized patient management</article-title>. <source/>Sci. Transl. Med.
<volume>3</volume>:<fpage>87r</fpage>e3. <pub-id pub-id-type="doi">10.1126/scitranslmed.3002243</pub-id><pub-id pub-id-type="pmid">21677200</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldridge</surname><given-names>D.</given-names></name><name><surname>Heeley</surname><given-names>J.</given-names></name><name><surname>Vineyard</surname><given-names>M.</given-names></name><name><surname>Manwaring</surname><given-names>L.</given-names></name><name><surname>Toler</surname><given-names>T. L.</given-names></name><name><surname>Fassi</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>The exome clinic and the role of medical genetics expertise in the interpretation of exome sequencing results</article-title>. <source/>Genet. Med.
<volume>19</volume>, <fpage>1040</fpage>–<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2016.224</pub-id><pub-id pub-id-type="pmid">28252636</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamshad</surname><given-names>M. J.</given-names></name><name><surname>Ng</surname><given-names>S. B.</given-names></name><name><surname>Bigham</surname><given-names>A. W.</given-names></name><name><surname>Tabor</surname><given-names>H. K.</given-names></name><name><surname>Emond</surname><given-names>M. J.</given-names></name><name><surname>Nickerson</surname><given-names>D. A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Exome sequencing as a tool for Mendelian disease gene discovery</article-title>. <source/>Nat. Rev. Genet.
<volume>12</volume>, <fpage>745</fpage>–<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3031</pub-id><pub-id pub-id-type="pmid">21946919</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcia</surname><given-names>G.</given-names></name><name><surname>Fleming</surname><given-names>M. R.</given-names></name><name><surname>Deligniere</surname><given-names>A.</given-names></name><name><surname>Gazula</surname><given-names>V.-R.</given-names></name><name><surname>Brown</surname><given-names>M. R.</given-names></name><name><surname>Langouet</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title><italic>De novo</italic> gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy</article-title>. <source/>Nat. Genet.
<volume>44</volume>, <fpage>1255</fpage>–<lpage>1259</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2441</pub-id><pub-id pub-id-type="pmid">23086397</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battaglia</surname><given-names>A.</given-names></name><name><surname>Bianchini</surname><given-names>E.</given-names></name><name><surname>Carey</surname><given-names>J. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neuropsychiatry</article-title>. <source/>Am. J. Med. Genet.
<volume>82</volume>, <fpage>60</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19990101)82:1&lt;60::AID-AJMG12&gt;3.0.CO;2-4</pub-id><pub-id pub-id-type="pmid">9916845</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battaglia</surname><given-names>A.</given-names></name><name><surname>Carey</surname><given-names>J. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Diagnostic evaluation of developmental delay/mental retardation: an overview</article-title>. <source/>Am. J. Med. Genet. Part C Semin. Med. Genet.
<volume>117</volume>, <fpage>3</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.10015</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergholdt</surname><given-names>R.</given-names></name><name><surname>Størling</surname><given-names>Z. M.</given-names></name><name><surname>Lage</surname><given-names>K.</given-names></name><name><surname>Karlberg</surname><given-names>E. O.</given-names></name><name><surname>Ólason</surname><given-names>P. Í.</given-names></name><name><surname>Aalund</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Integrative analysis for finding genes and networks involved in diabetes and other complex diseases</article-title>. <source/>Genome Biol.
<volume>8</volume>:<fpage>R253</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2007-8-11-r253</pub-id><pub-id pub-id-type="pmid">18045462</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancur</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting</article-title>. <source/>Brain Res.
<volume>1380</volume>, <fpage>42</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.11.078</pub-id><pub-id pub-id-type="pmid">21129364</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>D. R.</given-names></name><name><surname>Lyttle</surname><given-names>C. S.</given-names></name><name><surname>Mortensen</surname><given-names>J. M.</given-names></name><name><surname>Bearden</surname><given-names>C. F.</given-names></name><name><surname>Jensen</surname><given-names>A. B.</given-names></name><name><surname>Khiabanian</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>A nondegenerate code of deleterious variants in mendelian loci contributes to complex disease risk</article-title>. <source/>Cell
<volume>155</volume>, <fpage>70</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.08.030</pub-id><pub-id pub-id-type="pmid">24074861</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boycott</surname><given-names>K. M.</given-names></name><name><surname>Vanstone</surname><given-names>M. R.</given-names></name><name><surname>Bulman</surname><given-names>D. E.</given-names></name><name><surname>MacKenzie</surname><given-names>A. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Rare-disease genetics in the era of next-generation sequencing: discovery to translation</article-title>. <source/>Nat. Rev. Genet.
<volume>14</volume>, <fpage>681</fpage>–<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3555</pub-id><pub-id pub-id-type="pmid">23999272</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandler</surname><given-names>W. M.</given-names></name><name><surname>Antaki</surname><given-names>D.</given-names></name><name><surname>Gujral</surname><given-names>M.</given-names></name><name><surname>Kleiber</surname><given-names>M. L.</given-names></name><name><surname>Whitney</surname><given-names>J.</given-names></name><name><surname>Maile</surname><given-names>M. S.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Paternally inherited cis-regulatory structural variants are associated with autism</article-title>. <source/>Science
<volume>360</volume>, <fpage>327</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1126/science.aan.2261</pub-id><pub-id pub-id-type="pmid">29674594</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cappi</surname><given-names>C.</given-names></name><name><surname>Brentani</surname><given-names>H.</given-names></name><name><surname>Lima</surname><given-names>L.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Zai</surname><given-names>G.</given-names></name><name><surname>Diniz</surname><given-names>B. J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Whole-exome sequencing in obsessive-compulsive disorder identifies rare mutations in immunological and neurodevelopmental pathways</article-title>. <source/>Transl. Psychiatry
<volume>6</volume>:<fpage>e764</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2016.30</pub-id><pub-id pub-id-type="pmid">27023170</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>H.</given-names></name><name><surname>Douville</surname><given-names>C.</given-names></name><name><surname>Stenson</surname><given-names>P. D.</given-names></name><name><surname>Cooper</surname><given-names>D. N.</given-names></name><name><surname>Karchin</surname><given-names>R.</given-names></name></person-group> (<year>2013a</year>). <article-title>Identifying mendelian disease genes with the variant effect scoring tool</article-title>. <source/>BMC Genomics
<volume>14</volume>:<fpage>S3</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-14-S3-S3</pub-id><pub-id pub-id-type="pmid">23819870</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>H.</given-names></name><name><surname>Hofree</surname><given-names>M.</given-names></name><name><surname>Ideker</surname><given-names>T.</given-names></name></person-group> (<year>2013b</year>). <article-title>Genotype to phenotype via network analysis</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>23</volume>, <fpage>611</fpage>–<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2013.10.003</pub-id><pub-id pub-id-type="pmid">24238873</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Challman</surname><given-names>T. D.</given-names></name><name><surname>Barbaresi</surname><given-names>W. J.</given-names></name><name><surname>Katusic</surname><given-names>S. K.</given-names></name><name><surname>Weaver</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>The yield of the medical evaluation of children with pervasive developmental disorders</article-title>. <source/>J. Autism Dev. Disord.
<volume>33</volume>, <fpage>187</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1023/A:1022995611730</pub-id><pub-id pub-id-type="pmid">12757358</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Calhoun</surname><given-names>V. D.</given-names></name><name><surname>Perrone-Bizzozero</surname><given-names>N. I.</given-names></name><name><surname>Pearlson</surname><given-names>G. D.</given-names></name><name><surname>Sui</surname><given-names>J.</given-names></name><name><surname>Du</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>A pilot study on commonality and specificity of copy number variants in schizophrenia and bipolar disorder</article-title>. <source/>Transl. Psychiatry
<volume>6</volume>:<fpage>e824</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2016.96</pub-id><pub-id pub-id-type="pmid">27244233</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Davis</surname><given-names>L. K.</given-names></name><name><surname>Guter</surname><given-names>S.</given-names></name><name><surname>Wei</surname><given-names>Q.</given-names></name><name><surname>Jacob</surname><given-names>S.</given-names></name><name><surname>Potter</surname><given-names>M. H.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Leveraging blood serotonin as an endophenotype to identify <italic>de novo</italic> and rare variants involved in autism</article-title>. <source/>Mol. Autism
<volume>8</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/s13229-017-0130-3</pub-id><pub-id pub-id-type="pmid">28344757</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cline</surname><given-names>M. S.</given-names></name><name><surname>Smoot</surname><given-names>M.</given-names></name><name><surname>Cerami</surname><given-names>E.</given-names></name><name><surname>Kuchinsky</surname><given-names>A.</given-names></name><name><surname>Landys</surname><given-names>N.</given-names></name><name><surname>Workman</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Integration of biological networks and gene expression data using cytoscape</article-title>. <source/>Nat. Protoc.
<volume>2</volume>, <fpage>2366</fpage>–<lpage>2382</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.324</pub-id><pub-id pub-id-type="pmid">17947979</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>A. L.</given-names></name><name><surname>Sullivan</surname><given-names>P. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Genome-wide association studies in psychiatry: what have we learned?</article-title>
<source/>Br. J. Psychiatry
<volume>202</volume>, <fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.112.117002</pub-id><pub-id pub-id-type="pmid">23284144</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Cross-Disorder Group of the Psychiatric Genomics Consortium</collab><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Ripke</surname><given-names>S.</given-names></name><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Faraone</surname><given-names>S. V.</given-names></name><name><surname>Purcell</surname><given-names>S. M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs</article-title>. <source/>Nat. Genet.
<volume>45</volume>, <fpage>984</fpage>–<lpage>994</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2711</pub-id><pub-id pub-id-type="pmid">23933821</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>J. F.</given-names></name></person-group> (<year>2000</year>). <article-title>The origins, patterns and implications of human spontaneous mutation</article-title>. <source/>Nat. Rev. Genet.
<volume>1</volume>, <fpage>40</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/35049558</pub-id><pub-id pub-id-type="pmid">11262873</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daguenet</surname><given-names>E.</given-names></name><name><surname>Dujardin</surname><given-names>G.</given-names></name><name><surname>Valcárcel</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches</article-title>. <source/>EMBO Rep.
<volume>16</volume>, <fpage>1640</fpage>–<lpage>1655</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201541116</pub-id><pub-id pub-id-type="pmid">26566663</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davydov</surname><given-names>E. V.</given-names></name><name><surname>Goode</surname><given-names>D. L.</given-names></name><name><surname>Sirota</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>G. M.</given-names></name><name><surname>Sidow</surname><given-names>A.</given-names></name><name><surname>Batzoglou</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Identifying a high fraction of the human genome to be under selective constraint using GERP++</article-title>. <source/>PLoS Comput. Biol.
<volume>6</volume>:<fpage>e1001025</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1001025</pub-id><pub-id pub-id-type="pmid">21152010</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Boulle</surname><given-names>K.</given-names></name><name><surname>Verkerk</surname><given-names>A. J. M. H.</given-names></name><name><surname>Reyniers</surname><given-names>E.</given-names></name><name><surname>Vits</surname><given-names>L.</given-names></name><name><surname>Hendrickx</surname><given-names>J.</given-names></name><name><surname>Van Roy</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>1993</year>). <article-title>A point mutation in the FMR-1 gene associated with fragile X mental retardation</article-title>. <source/>Nat. Genet.
<volume>3</volume>, <fpage>31</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1038/ng0193-31</pub-id><pub-id pub-id-type="pmid">8490650</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Hert</surname><given-names>M.</given-names></name><name><surname>Steemans</surname><given-names>D.</given-names></name><name><surname>Theys</surname><given-names>P.</given-names></name><name><surname>Fryns</surname><given-names>J.-P.</given-names></name><name><surname>Peuskens</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Lujan-Fryns syndrome in the differential diagnosis of schizophrenia</article-title>. <source/>Am. J. Med. Genet.
<volume>67</volume>, <fpage>212</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19960409)67:2&lt;212::AID-AJMG13&gt;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">8723050</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Ligt</surname><given-names>J.</given-names></name><name><surname>Willemsen</surname><given-names>M. H.</given-names></name><name><surname>van Bon</surname><given-names>B. W.</given-names></name><name><surname>Kleefstra</surname><given-names>T.</given-names></name><name><surname>Yntema</surname><given-names>H. G.</given-names></name><name><surname>Kroes</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>. <source/>N. Engl. J. Med.
<volume>20367</volume>, <fpage>1921</fpage>–<lpage>1929</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1206524</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Poultney</surname><given-names>C. S.</given-names></name><name><surname>Samocha</surname><given-names>K.</given-names></name><name><surname>Ercument Cicek</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source/>Nature
<volume>515</volume>, <fpage>209</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1038/nature13772</pub-id><pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Deciphering Developmental Disorders Study</collab><name><surname>McRae</surname><given-names>J. F.</given-names></name><name><surname>Clayton</surname><given-names>S.</given-names></name><name><surname>Fitzgerald</surname><given-names>T. W.</given-names></name><name><surname>Kaplanis</surname><given-names>J.</given-names></name><name><surname>Prigmore</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Prevalence and architecture of <italic>de novo</italic> mutations in developmental disorders</article-title>. <source/>Nature
<volume>542</volume>, <fpage>433</fpage>–<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1038/nature21062</pub-id><pub-id pub-id-type="pmid">28135719</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desmet</surname><given-names>F.-O.</given-names></name><name><surname>Hamroun</surname><given-names>D.</given-names></name><name><surname>Lalande</surname><given-names>M.</given-names></name><name><surname>Collod-Béroud</surname><given-names>G.</given-names></name><name><surname>Claustres</surname><given-names>M.</given-names></name><name><surname>Béroud</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>Human splicing finder: an online bioinformatics tool to predict splicing signals</article-title>. <source/>Nucleic Acids Res.
<volume>37</volume>:<fpage>e67</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp215</pub-id><pub-id pub-id-type="pmid">19339519</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon-Salazar</surname><given-names>T. J.</given-names></name><name><surname>Silhavy</surname><given-names>J. L.</given-names></name><name><surname>Udpa</surname><given-names>N.</given-names></name><name><surname>Schroth</surname><given-names>J.</given-names></name><name><surname>Bielas</surname><given-names>S.</given-names></name><name><surname>Schaffer</surname><given-names>A. E.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Exome sequencing can improve diagnosis and alter patient management</article-title>. <source/>Sci. Transl. Med.
<volume>4</volume>:<fpage>138r</fpage>a78. <pub-id pub-id-type="doi">10.1126/scitranslmed.3003544</pub-id><pub-id pub-id-type="pmid">22700954</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>C.</given-names></name><name><surname>Wei</surname><given-names>P.</given-names></name><name><surname>Jian</surname><given-names>X.</given-names></name><name><surname>Gibbs</surname><given-names>R.</given-names></name><name><surname>Boerwinkle</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>2125</fpage>–<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu733</pub-id><pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epi4k Consortium</surname><given-names>E.</given-names></name><name><surname>Allen</surname><given-names>A. S.</given-names></name><name><surname>Berkovic</surname><given-names>S. F.</given-names></name><name><surname>Cossette</surname><given-names>P.</given-names></name><name><surname>Delanty</surname><given-names>N.</given-names></name><name><surname>Dlugos</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title><italic>De novo</italic> mutations in epileptic encephalopathies</article-title>. <source/>Nature
<volume>501</volume>, <fpage>217</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature12439</pub-id><pub-id pub-id-type="pmid">23934111</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>S. V.</given-names></name><name><surname>Biederman</surname><given-names>J.</given-names></name><name><surname>Wozniak</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: a meta-analysis of family genetic studies</article-title>. <source/>Am. J. Psychiatry
<volume>169</volume>, <fpage>1256</fpage>–<lpage>1266</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2012.12010087</pub-id><pub-id pub-id-type="pmid">23212057</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farwell</surname><given-names>K. D.</given-names></name><name><surname>Shahmirzadi</surname><given-names>L.</given-names></name><name><surname>El-Khechen</surname><given-names>D.</given-names></name><name><surname>Powis</surname><given-names>Z.</given-names></name><name><surname>Chao</surname><given-names>E. C.</given-names></name><name><surname>Tippin Davis</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions</article-title>. <source/>Genet. Med.
<volume>17</volume>, <fpage>578</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2014.154</pub-id><pub-id pub-id-type="pmid">25356970</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogel</surname><given-names>B. L.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Deignan</surname><given-names>J. L.</given-names></name><name><surname>Strom</surname><given-names>S. P.</given-names></name><name><surname>Kantarci</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia</article-title>. <source/>JAMA Neurol.
<volume>71</volume>, <fpage>1237</fpage>–<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2014.1944</pub-id><pub-id pub-id-type="pmid">25133958</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fokkema</surname><given-names>I. F. A. C.</given-names></name><name><surname>Taschner</surname><given-names>P. E. M.</given-names></name><name><surname>Schaafsma</surname><given-names>G. C. P.</given-names></name><name><surname>Celli</surname><given-names>J.</given-names></name><name><surname>Laros</surname><given-names>J. F. J.</given-names></name><name><surname>den Dunnen</surname><given-names>J. T.</given-names></name></person-group> (<year>2011</year>). <article-title>LOVD v.2.0: the next generation in gene variant databases</article-title>. <source/>Hum. Mutat.
<volume>32</volume>, <fpage>557</fpage>–<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21438</pub-id><pub-id pub-id-type="pmid">21520333</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francioli</surname><given-names>L. C.</given-names></name><name><surname>Menelaou</surname><given-names>A.</given-names></name><name><surname>Pulit</surname><given-names>S. L.</given-names></name><name><surname>van Dijk</surname><given-names>F.</given-names></name><name><surname>Palamara</surname><given-names>P. F.</given-names></name><name><surname>Elbers</surname><given-names>C. C.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Whole-genome sequence variation, population structure and demographic history of the Dutch population</article-title>. <source/>Nat. Genet.
<volume>46</volume>, <fpage>818</fpage>–<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3021</pub-id><pub-id pub-id-type="pmid">24974849</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fromer</surname><given-names>M.</given-names></name><name><surname>Pocklington</surname><given-names>A. J.</given-names></name><name><surname>Kavanagh</surname><given-names>D. H.</given-names></name><name><surname>Williams</surname><given-names>H. J.</given-names></name><name><surname>Dwyer</surname><given-names>S.</given-names></name><name><surname>Gormley</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title><italic>De novo</italic> mutations in schizophrenia implicate synaptic networks</article-title>. <source/>Nature
<volume>506</volume>, <fpage>179</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/nature12929</pub-id><pub-id pub-id-type="pmid">24463507</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furlong</surname><given-names>L. I.</given-names></name></person-group> (<year>2013</year>). <article-title>Human diseases through the lens of network biology</article-title>. <source/>Trends Genet.
<volume>29</volume>, <fpage>150</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2012.11.004</pub-id><pub-id pub-id-type="pmid">23219555</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname><given-names>M. J.</given-names></name><name><surname>Haney</surname><given-names>J. R.</given-names></name><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Leppa</surname><given-names>V.</given-names></name><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Hartl</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap</article-title>. <source/>Science
<volume>359</volume>, <fpage>693</fpage>–<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad6469</pub-id><pub-id pub-id-type="pmid">29439242</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname><given-names>M. J.</given-names></name><name><surname>Leppa</surname><given-names>V.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2016</year>). <article-title>The road to precision psychiatry: translating genetics into disease mechanisms</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>1397</fpage>–<lpage>1407</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4409</pub-id><pub-id pub-id-type="pmid">27786179</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genovese</surname><given-names>G.</given-names></name><name><surname>Fromer</surname><given-names>M.</given-names></name><name><surname>Stahl</surname><given-names>E. A.</given-names></name><name><surname>Ruderfer</surname><given-names>D. M.</given-names></name><name><surname>Chambert</surname><given-names>K.</given-names></name><name><surname>Landén</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>1433</fpage>–<lpage>1441</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4402</pub-id><pub-id pub-id-type="pmid">27694994</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><name><surname>Konopka</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuroscience in the era of functional genomics and systems biology</article-title>. <source/>Nature
<volume>461</volume>, <fpage>908</fpage>–<lpage>915</lpage>. <pub-id pub-id-type="doi">10.1038/nature08537</pub-id><pub-id pub-id-type="pmid">19829370</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>R. A.</given-names></name><name><surname>Boerwinkle</surname><given-names>E.</given-names></name><name><surname>Doddapaneni</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Korchina</surname><given-names>V.</given-names></name><name><surname>Kovar</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A global reference for human genetic variation</article-title>. <source/>Nature
<volume>526</volume>, <fpage>68</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/nature15393</pub-id><pub-id pub-id-type="pmid">26432245</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilissen</surname><given-names>C.</given-names></name><name><surname>Hehir-Kwa</surname><given-names>J. Y.</given-names></name><name><surname>Thung</surname><given-names>D. T.</given-names></name><name><surname>van de Vorst</surname><given-names>M.</given-names></name><name><surname>van Bon</surname><given-names>B. W. M.</given-names></name><name><surname>Willemsen</surname><given-names>M. H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Genome sequencing identifies major causes of severe intellectual disability</article-title>. <source/>Nature
<volume>511</volume>, <fpage>344</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1038/nature13394</pub-id><pub-id pub-id-type="pmid">24896178</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname><given-names>S. R.</given-names></name><name><surname>Chang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Bawa</surname><given-names>T. S.</given-names></name><name><surname>Gogos</surname><given-names>J. A.</given-names></name><name><surname>Karayiorgou</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Diverse types of genetic variation converge on functional gene networks involved in schizophrenia</article-title>. <source/>Nat. Neurosci.
<volume>15</volume>, <fpage>1723</fpage>–<lpage>1728</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3261</pub-id><pub-id pub-id-type="pmid">23143521</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>S. L.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Noreau</surname><given-names>A.</given-names></name><name><surname>Xiong</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Jouan</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Increased exonic <italic>de novo</italic> mutation rate in individuals with schizophrenia</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>860</fpage>–<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1038/ng.886</pub-id><pub-id pub-id-type="pmid">21743468</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Campbell</surname><given-names>C. D.</given-names></name><name><surname>Eichler</surname><given-names>E. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Human copy number variation and complex genetic disease</article-title>. <source/>Annu. Rev. Genet.
<volume>45</volume>, <fpage>203</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-102209-163544</pub-id><pub-id pub-id-type="pmid">21854229</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gnad</surname><given-names>F.</given-names></name><name><surname>Baucom</surname><given-names>A.</given-names></name><name><surname>Mukhyala</surname><given-names>K.</given-names></name><name><surname>Manning</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2013</year>). <article-title>Assessment of computational methods for predicting the effects of missense mutations in human cancers</article-title>. <source/>BMC Genomics
<volume>14</volume> (<issue>Suppl. 3</issue>):<fpage>S7</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-14-S3-S7</pub-id><pub-id pub-id-type="pmid">23819521</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goes</surname><given-names>F. S.</given-names></name><name><surname>Pirooznia</surname><given-names>M.</given-names></name><name><surname>Parla</surname><given-names>J. S.</given-names></name><name><surname>Kramer</surname><given-names>M.</given-names></name><name><surname>Ghiban</surname><given-names>E.</given-names></name><name><surname>Mavruk</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Exome sequencing of familial bipolar disorder</article-title>. <source/>JAMA Psychiatry
<volume>73</volume>, <fpage>590</fpage>–<lpage>597</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2016.0251</pub-id><pub-id pub-id-type="pmid">27120077</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>D. B.</given-names></name><name><surname>Allen</surname><given-names>A.</given-names></name><name><surname>Keebler</surname><given-names>J.</given-names></name><name><surname>Margulies</surname><given-names>E. H.</given-names></name><name><surname>Petrou</surname><given-names>S.</given-names></name><name><surname>Petrovski</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Sequencing studies in human genetics: design and interpretation</article-title>. <source/>Nat. Rev. Genet.
<volume>14</volume>, <fpage>460</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3455</pub-id><pub-id pub-id-type="pmid">23752795</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratten</surname><given-names>J.</given-names></name><name><surname>Visscher</surname><given-names>P. M.</given-names></name><name><surname>Mowry</surname><given-names>B. J.</given-names></name><name><surname>Wray</surname><given-names>N. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Interpreting the role of <italic>de novo</italic> protein-coding mutations in neuropsychiatric disease</article-title>. <source/>Nat. Genet.
<volume>45</volume>, <fpage>234</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2555</pub-id><pub-id pub-id-type="pmid">23438595</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratten</surname><given-names>J.</given-names></name><name><surname>Wray</surname><given-names>N. R.</given-names></name><name><surname>Keller</surname><given-names>M. C.</given-names></name><name><surname>Visscher</surname><given-names>P. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Large-scale genomics unveils the genetic architecture of psychiatric disorders</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>782</fpage>–<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3708</pub-id><pub-id pub-id-type="pmid">24866044</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname><given-names>D. G.</given-names></name><name><surname>Azencott</surname><given-names>C.-A.</given-names></name><name><surname>Aicheler</surname><given-names>F.</given-names></name><name><surname>Gieraths</surname><given-names>U.</given-names></name><name><surname>MacArthur</surname><given-names>D. G.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity</article-title>. <source/>Hum. Mutat.
<volume>36</volume>, <fpage>513</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22768</pub-id><pub-id pub-id-type="pmid">25684150</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerreiro</surname><given-names>R.</given-names></name><name><surname>Bras</surname><given-names>J.</given-names></name><name><surname>Hardy</surname><given-names>J.</given-names></name><name><surname>Singleton</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations</article-title>. <source/>Hum. Mol. Genet.
<volume>23</volume>, <fpage>R47</fpage>–<lpage>R53</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu203</pub-id><pub-id pub-id-type="pmid">24794858</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guipponi</surname><given-names>M.</given-names></name><name><surname>Santoni</surname><given-names>F. A.</given-names></name><name><surname>Setola</surname><given-names>V.</given-names></name><name><surname>Gehrig</surname><given-names>C.</given-names></name><name><surname>Rotharmel</surname><given-names>M.</given-names></name><name><surname>Cuenca</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e112745</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112745</pub-id><pub-id pub-id-type="pmid">25420024</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulsuner</surname><given-names>S.</given-names></name><name><surname>Walsh</surname><given-names>T.</given-names></name><name><surname>Watts</surname><given-names>A. C.</given-names></name><name><surname>Lee</surname><given-names>M. K.</given-names></name><name><surname>Thornton</surname><given-names>A. M.</given-names></name><name><surname>Casadei</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Spatial and temporal mapping of <italic>de novo</italic> mutations in schizophrenia to a fetal prefrontal cortical network</article-title>. <source/>Cell
<volume>154</volume>, <fpage>518</fpage>–<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.06.049</pub-id><pub-id pub-id-type="pmid">23911319</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Ellis</surname><given-names>S. E.</given-names></name><name><surname>Ashar</surname><given-names>F. N.</given-names></name><name><surname>Moes</surname><given-names>A.</given-names></name><name><surname>Bader</surname><given-names>J. S.</given-names></name><name><surname>Zhan</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>5748</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms6748</pub-id><pub-id pub-id-type="pmid">25494366</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halvardson</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>J. J.</given-names></name><name><surname>Zaghlool</surname><given-names>A.</given-names></name><name><surname>Wentzel</surname><given-names>C.</given-names></name><name><surname>Georgii-Hemming</surname><given-names>P.</given-names></name><name><surname>Månsson</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Mutations in HECW2 are associated with intellectual disability and epilepsy</article-title>. <source/>J. Med. Genet.
<volume>53</volume>, <fpage>697</fpage>–<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2016-103814</pub-id><pub-id pub-id-type="pmid">27334371</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Myers</surname><given-names>C. T.</given-names></name><name><surname>Cossette</surname><given-names>P.</given-names></name><name><surname>Lemay</surname><given-names>P.</given-names></name><name><surname>Spiegelman</surname><given-names>D.</given-names></name><name><surname>Laporte</surname><given-names>A. D.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>High rate of recurrent <italic>de novo</italic> mutations in developmental and epileptic encephalopathies</article-title>. <source/>Am. J. Hum. Genet.
<volume>101</volume>, <fpage>664</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.09.008</pub-id><pub-id pub-id-type="pmid">29100083</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Srour</surname><given-names>M.</given-names></name><name><surname>Capo-Chichi</surname><given-names>J.-M.</given-names></name><name><surname>Daoud</surname><given-names>H.</given-names></name><name><surname>Nassif</surname><given-names>C.</given-names></name><name><surname>Patry</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title><italic>De novo</italic> mutations in moderate or severe intellectual disability</article-title>. <source/>PLoS Genet.
<volume>10</volume>:<fpage>e1004772</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004772</pub-id><pub-id pub-id-type="pmid">25356899</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>R.</given-names></name><name><surname>Nakazawa</surname><given-names>T.</given-names></name><name><surname>Tsurusaki</surname><given-names>Y.</given-names></name><name><surname>Yasuda</surname><given-names>Y.</given-names></name><name><surname>Nagayasu</surname><given-names>K.</given-names></name><name><surname>Matsumura</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder</article-title>. <source/>J. Hum. Genet.
<volume>61</volume>, <fpage>199</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1038/jhg.2015.141</pub-id><pub-id pub-id-type="pmid">26582266</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>Lim</surname><given-names>E. T.</given-names></name><name><surname>Sutcliffe</surname><given-names>J. S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Integrated model of <italic>de novo</italic> and inherited genetic variants yields greater power to identify risk genes</article-title>. <source/>PLoS Genet.
<volume>9</volume>:<fpage>e1003671</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003671</pub-id><pub-id pub-id-type="pmid">23966865</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helbig</surname><given-names>K. L.</given-names></name><name><surname>Farwell Hagman</surname><given-names>K. D.</given-names></name><name><surname>Shinde</surname><given-names>D. N.</given-names></name><name><surname>Mroske</surname><given-names>C.</given-names></name><name><surname>Powis</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy</article-title>. <source/>Genet. Med.
<volume>18</volume>, <fpage>898</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.186</pub-id><pub-id pub-id-type="pmid">26795593</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirschtritt</surname><given-names>M. E.</given-names></name><name><surname>Darrow</surname><given-names>S. M.</given-names></name><name><surname>Illmann</surname><given-names>C.</given-names></name><name><surname>Osiecki</surname><given-names>L.</given-names></name><name><surname>Grados</surname><given-names>M.</given-names></name><name><surname>Sandor</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Genetic and phenotypic overlap of specific obsessive-compulsive and attention-deficit/hyperactive subtypes with Tourette syndrome</article-title>. <source/>Psychol. Med.
<volume>48</volume>, <fpage>279</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291717001672</pub-id><pub-id pub-id-type="pmid">28651666</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>N.</given-names></name><name><surname>Buchanan</surname><given-names>J. A.</given-names></name><name><surname>Scherer</surname><given-names>S. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders</article-title>. <source/>NPJ Genomic Med.
<volume>3</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.1038/s41525-018-0066-3</pub-id><pub-id pub-id-type="pmid">30275975</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horwitz</surname><given-names>T.</given-names></name><name><surname>Lam</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>A decade in psychiatric GWAS research</article-title>. <source/>Mol. Psychiatry
<volume>24</volume>, <fpage>378</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-018-0055-z</pub-id><pub-id pub-id-type="pmid">29942042</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>L.</given-names></name><name><surname>Bergen</surname><given-names>S. E.</given-names></name><name><surname>Akula</surname><given-names>N.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Hultman</surname><given-names>C. M.</given-names></name><name><surname>Landén</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder</article-title>. <source/>Hum. Mol. Genet.
<volume>25</volume>, <fpage>3383</fpage>–<lpage>3394</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw181</pub-id><pub-id pub-id-type="pmid">27329760</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.-F.</given-names></name><name><surname>Gulko</surname><given-names>B.</given-names></name><name><surname>Siepel</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>618</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3810</pub-id><pub-id pub-id-type="pmid">28288115</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>M.</given-names></name><name><surname>Takahashi</surname><given-names>A.</given-names></name><name><surname>Kamatani</surname><given-names>Y.</given-names></name><name><surname>Okahisa</surname><given-names>Y.</given-names></name><name><surname>Kunugi</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder</article-title>. <source/>Mol. Psychiatry
<volume>23</volume>, <fpage>639</fpage>–<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.259</pub-id><pub-id pub-id-type="pmid">28115744</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Lupski</surname><given-names>J. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Genetics and genomics of behavioral and psychiatric disorders</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>13</volume>, <fpage>303</fpage>–<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/S0959-437X(03)00057-1</pub-id><pub-id pub-id-type="pmid">12787794</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>N. M.</given-names></name><name><surname>Rothstein</surname><given-names>J. H.</given-names></name><name><surname>Pejaver</surname><given-names>V.</given-names></name><name><surname>Middha</surname><given-names>S.</given-names></name><name><surname>McDonnell</surname><given-names>S. K.</given-names></name><name><surname>Baheti</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>REVEL: an ensemble method for predicting the pathogenicity of rare missense variants</article-title>. <source/>Am. J. Hum. Genet.
<volume>99</volume>, <fpage>877</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.08.016</pub-id><pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ionita-Laza</surname><given-names>I.</given-names></name><name><surname>Mccallum</surname><given-names>K.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Buxbaum</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>A spectral approach integrating functional genomic annotations for coding and noncoding variants HHS public access</article-title>. <source/>Nat. Genet.
<volume>48</volume>, <fpage>214</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3477</pub-id><pub-id pub-id-type="pmid">26727659</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The contribution of <italic>de novo</italic> coding mutations to autism spectrum disorder</article-title>. <source/>Nature
<volume>515</volume>, <fpage>216</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id><pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Hakker</surname><given-names>I.</given-names></name><name><surname>Rosenbaum</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title><italic>De novo</italic> gene disruptions in children on the autistic spectrum</article-title>. <source/>Neuron
<volume>74</volume>, <fpage>285</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.009</pub-id><pub-id pub-id-type="pmid">22542183</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname><given-names>X.</given-names></name><name><surname>Boerwinkle</surname><given-names>E.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name></person-group> (<year>2014</year>). <article-title>In silico tools for splicing defect prediction: a survey from the viewpoint of end users</article-title>. <source/>Genet. Med.
<volume>16</volume>, <fpage>497</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2013.176</pub-id><pub-id pub-id-type="pmid">24263461</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Du</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>mirDNMR: a gene-centered database of background <italic>de novo</italic> mutation rates in human</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>D796</fpage>–<lpage>D803</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1044</pub-id><pub-id pub-id-type="pmid">27799474</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Yuen</surname><given-names>R. K. C.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing</article-title>. <source/>Am. J. Hum. Genet.
<volume>93</volume>, <fpage>249</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.06.012</pub-id><pub-id pub-id-type="pmid">23849776</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>W.</given-names></name><name><surname>Alasoo</surname><given-names>K.</given-names></name><name><surname>Fishman</surname><given-names>D.</given-names></name><name><surname>Parts</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Computational biology: deep learning</article-title>. <source/>Emerg. Top. Life Sci.
<volume>1</volume>, <fpage>257</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1042/ETLS20160025</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>. <source/>Nucleic Acids Res.
<volume>28</volume>, <fpage>27</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><pub-id pub-id-type="pmid">10592173</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>M.</given-names></name><name><surname>Matoba</surname><given-names>N.</given-names></name><name><surname>Sawada</surname><given-names>T.</given-names></name><name><surname>Kazuno</surname><given-names>A.-A.</given-names></name><name><surname>Ishiwata</surname><given-names>M.</given-names></name><name><surname>Fujii</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Exome sequencing for bipolar disorder points to roles of <italic>de novo</italic> loss-of-function and protein-altering mutations</article-title>. <source/>Mol. Psychiatry
<volume>21</volume>, <fpage>885</fpage>–<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.69</pub-id><pub-id pub-id-type="pmid">27217147</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D. S.</given-names></name><name><surname>Burt</surname><given-names>A. A.</given-names></name><name><surname>Ranchalis</surname><given-names>J. E.</given-names></name><name><surname>Wilmot</surname><given-names>B.</given-names></name><name><surname>Smith</surname><given-names>J. D.</given-names></name><name><surname>Patterson</surname><given-names>K. E.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Sequencing of sporadic Attention-Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic <italic>de novo</italic> variants and excludes overlap with genes associated with autism spectrum disorder</article-title>. <source/>Am. J. Med. Genet. Part B Neuropsychiatr. Genet.
<volume>174</volume>, <fpage>381</fpage>–<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32527</pub-id><pub-id pub-id-type="pmid">28332277</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingsmore</surname><given-names>S. F.</given-names></name><name><surname>Saunders</surname><given-names>C. J.</given-names></name><name><surname>Miller</surname><given-names>N. A.</given-names></name><name><surname>Hateley</surname><given-names>S. L.</given-names></name><name><surname>Ganusova</surname><given-names>E. E.</given-names></name><name><surname>Mudge</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Deep sequencing of patient genomes for disease diagnosis: when will it become routine?</article-title>
<source/>Sci. Transl. Med.
<volume>3</volume>:<fpage>87p</fpage>s23. <pub-id pub-id-type="doi">10.1126/scitranslmed.3002695</pub-id><pub-id pub-id-type="pmid">21677196</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kircher</surname><given-names>M.</given-names></name><name><surname>Witten</surname><given-names>D. M.</given-names></name><name><surname>Jain</surname><given-names>P.</given-names></name><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Cooper</surname><given-names>G. M.</given-names></name><name><surname>Shendure</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source/>Nat. Genet.
<volume>46</volume>, <fpage>310</fpage>–<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2892</pub-id><pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohler</surname><given-names>K.</given-names></name><name><surname>Bickeboller</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Case-Control association tests correcting for population stratification</article-title>. <source/>Ann. Hum. Genet.
<volume>70</volume>, <fpage>98</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1111/j.1529-8817.2005.00214.x</pub-id><pub-id pub-id-type="pmid">16441260</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>S.</given-names></name><name><surname>Vasilevsky</surname><given-names>N. A.</given-names></name><name><surname>Engelstad</surname><given-names>M.</given-names></name><name><surname>Foster</surname><given-names>E.</given-names></name><name><surname>McMurry</surname><given-names>J.</given-names></name><name><surname>Aymé</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>The human phenotype ontology in 2017</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>D865</fpage>–<lpage>D876</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1039</pub-id><pub-id pub-id-type="pmid">27899602</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>A.</given-names></name><name><surname>Frigge</surname><given-names>M. L.</given-names></name><name><surname>Masson</surname><given-names>G.</given-names></name><name><surname>Besenbacher</surname><given-names>S.</given-names></name><name><surname>Sulem</surname><given-names>P.</given-names></name><name><surname>Magnusson</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Rate of <italic>de novo</italic> mutations and the importance of father's age to disease risk</article-title>. <source/>Nature
<volume>488</volume>, <fpage>471</fpage>–<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1038/nature11396</pub-id><pub-id pub-id-type="pmid">22914163</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kranz</surname><given-names>T. M.</given-names></name><name><surname>Harroch</surname><given-names>S.</given-names></name><name><surname>Manor</surname><given-names>O.</given-names></name><name><surname>Lichtenberg</surname><given-names>P.</given-names></name><name><surname>Friedlander</surname><given-names>Y.</given-names></name><name><surname>Seandel</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title><italic>De novo</italic> mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample</article-title>. <source/>Schizophr. Res.
<volume>166</volume>, <fpage>119</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2015.05.042</pub-id><pub-id pub-id-type="pmid">26091878</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawczak</surname><given-names>M.</given-names></name><name><surname>Thomas</surname><given-names>N. S. T.</given-names></name><name><surname>Hundrieser</surname><given-names>B.</given-names></name><name><surname>Mort</surname><given-names>M.</given-names></name><name><surname>Wittig</surname><given-names>M.</given-names></name><name><surname>Hampe</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Single base-pair substitutions in exon-intron junctions of human genes: nature, distribution, and consequences for mRNA splicing</article-title>. <source/>Hum. Mutat.
<volume>28</volume>, <fpage>150</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20400</pub-id><pub-id pub-id-type="pmid">17001642</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Turner</surname><given-names>T. N.</given-names></name><name><surname>Baker</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Mohajeri</surname><given-names>K.</given-names></name><name><surname>Witherspoon</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Excess of rare, inherited truncating mutations in autism</article-title>. <source/>Nat. Genet.
<volume>47</volume>, <fpage>582</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3303</pub-id><pub-id pub-id-type="pmid">25961944</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kun-Rodrigues</surname><given-names>C.</given-names></name><name><surname>Ganos</surname><given-names>C.</given-names></name><name><surname>Guerreiro</surname><given-names>R.</given-names></name><name><surname>Schneider</surname><given-names>S. A.</given-names></name><name><surname>Schulte</surname><given-names>C.</given-names></name><name><surname>Lesage</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A systematic screening to identify <italic>de novo</italic> mutations causing sporadic early-onset Parkinson's disease</article-title>. <source/>Hum. Mol. Genet.
<volume>24</volume>, <fpage>6711</fpage>–<lpage>6720</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv376</pub-id><pub-id pub-id-type="pmid">26362251</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lage</surname><given-names>K.</given-names></name><name><surname>Hansen</surname><given-names>N. T.</given-names></name><name><surname>Karlberg</surname><given-names>E. O.</given-names></name><name><surname>Eklund</surname><given-names>A. C.</given-names></name><name><surname>Roque</surname><given-names>F. S.</given-names></name><name><surname>Donahoe</surname><given-names>P. K.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>105</volume>, <fpage>20870</fpage>–<lpage>20875</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0810772105</pub-id><pub-id pub-id-type="pmid">19104045</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landrum</surname><given-names>M. J.</given-names></name><name><surname>Lee</surname><given-names>J. M.</given-names></name><name><surname>Benson</surname><given-names>M.</given-names></name><name><surname>Brown</surname><given-names>G.</given-names></name><name><surname>Chao</surname><given-names>C.</given-names></name><name><surname>Chitipiralla</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>ClinVar: public archive of interpretations of clinically relevant variants</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>D862</fpage>–<lpage>D868</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1222</pub-id><pub-id pub-id-type="pmid">26582918</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanoiselée</surname><given-names>H.-M.</given-names></name><name><surname>Nicolas</surname><given-names>G.</given-names></name><name><surname>Wallon</surname><given-names>D.</given-names></name><name><surname>Rovelet-Lecrux</surname><given-names>A.</given-names></name><name><surname>Lacour</surname><given-names>M.</given-names></name><name><surname>Rousseau</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases</article-title>. <source/>PLoS Med.
<volume>14</volume>:<fpage>e1002270</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002270</pub-id><pub-id pub-id-type="pmid">28350801</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeCun</surname><given-names>Y.</given-names></name><name><surname>Bengio</surname><given-names>Y.</given-names></name><name><surname>Hinton</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Deep learning</article-title>. <source/>Nature
<volume>521</volume>, <fpage>436</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1038/nature14539</pub-id><pub-id pub-id-type="pmid">26017442</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Deignan</surname><given-names>J. L.</given-names></name><name><surname>Dorrani</surname><given-names>N.</given-names></name><name><surname>Strom</surname><given-names>S. P.</given-names></name><name><surname>Kantarci</surname><given-names>S.</given-names></name><name><surname>Quintero-Rivera</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Clinical exome sequencing for genetic identification of rare mendelian disorders</article-title>. <source/>JAMA
<volume>312</volume>, <fpage>1880</fpage>–<lpage>1887</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.14604</pub-id><pub-id pub-id-type="pmid">25326637</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lek</surname><given-names>M.</given-names></name><name><surname>Karczewski</surname><given-names>K. J.</given-names></name><name><surname>Minikel</surname><given-names>E. V.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Banks</surname><given-names>E.</given-names></name><name><surname>Fennell</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature
<volume>536</volume>, <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id><pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lelieveld</surname><given-names>S. H.</given-names></name><name><surname>Reijnders</surname><given-names>M. R. F.</given-names></name><name><surname>Pfundt</surname><given-names>R.</given-names></name><name><surname>Yntema</surname><given-names>H. G.</given-names></name><name><surname>Kamsteeg</surname><given-names>E.-J.</given-names></name><name><surname>de Vries</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability</article-title>. <source/>Nat. Neurosci.
<volume>19</volume>, <fpage>1194</fpage>–<lpage>1196</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4352</pub-id><pub-id pub-id-type="pmid">27479843</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lencz</surname><given-names>T.</given-names></name><name><surname>Malhotra</surname><given-names>A. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic</article-title>. <source/>Mol. Psychiatry
<volume>20</volume>, <fpage>820</fpage>–<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.28</pub-id><pub-id pub-id-type="pmid">25869805</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>T.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Genes with <italic>de novo</italic> mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database</article-title>. <source/>Mol. Psychiatry
<volume>21</volume>, <fpage>290</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.40</pub-id><pub-id pub-id-type="pmid">25849321</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Performance evaluation of pathogenicity-computation methods for missense variants</article-title>. <source/>Nucleic Acids Res.
<volume>46</volume>, <fpage>7793</fpage>–<lpage>7804</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky678</pub-id><pub-id pub-id-type="pmid">30060008</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Carlström</surname><given-names>E.</given-names></name><name><surname>Råstam</surname><given-names>M.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name><name><surname>Anckarsäter</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood</article-title>. <source/>Am. J. Psychiatry
<volume>167</volume>, <fpage>1357</fpage>–<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2010.10020223</pub-id><pub-id pub-id-type="pmid">20686188</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>G. N.</given-names></name><name><surname>Corominas</surname><given-names>R.</given-names></name><name><surname>Lemmens</surname><given-names>I.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Tavernier</surname><given-names>J.</given-names></name><name><surname>Hill</surname><given-names>D. E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Spatiotemporal 16p11.2 protein network implicates cortical late mid-fetal brain development and KCTD13-Cul3-RhoA pathway in psychiatric diseases</article-title>. <source/>Neuron
<volume>85</volume>, <fpage>742</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.01.010</pub-id><pub-id pub-id-type="pmid">25695269</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Shimada</surname><given-names>T.</given-names></name><name><surname>Otowa</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>Y.-Y.</given-names></name><name><surname>Kawamura</surname><given-names>Y.</given-names></name><name><surname>Tochigi</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016a</year>). <article-title>Genome-wide association study of autism spectrum disorder in the east asian populations</article-title>. <source/>Autism Res.
<volume>9</volume>, <fpage>340</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1536</pub-id><pub-id pub-id-type="pmid">26314684</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Boerwinkle</surname><given-names>E.</given-names></name></person-group> (<year>2016b</year>). <article-title>dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs</article-title>. <source/>Hum. Mutat.
<volume>37</volume>, <fpage>235</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22932</pub-id><pub-id pub-id-type="pmid">26555599</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Switch from previous major depression comorbid with CLIPPERS to mania-like episode following glucocorticosteroid therapy: a case report</article-title>. <source/>Gen. Psychiatry
<volume>31</volume>:<fpage>e000007</fpage>. <pub-id pub-id-type="doi">10.1136/gpsych-2018-000007</pub-id><pub-id pub-id-type="pmid">30582117</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J. T.</given-names></name><name><surname>Campeau</surname><given-names>P. M.</given-names></name><name><surname>Lee</surname><given-names>B. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Genotype–Phenotype correlation — promiscuity in the era of next-generation sequencing</article-title>. <source/>N. Engl. J. Med.
<volume>371</volume>, <fpage>593</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMp1400788</pub-id><pub-id pub-id-type="pmid">25119605</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacArthur</surname><given-names>D. G.</given-names></name><name><surname>Manolio</surname><given-names>T. A.</given-names></name><name><surname>Dimmock</surname><given-names>D. P.</given-names></name><name><surname>Rehm</surname><given-names>H. L.</given-names></name><name><surname>Shendure</surname><given-names>J.</given-names></name><name><surname>Abecasis</surname><given-names>G. R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Guidelines for investigating causality of sequence variants in human disease</article-title>. <source/>Nature
<volume>508</volume>, <fpage>469</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1038/nature13127</pub-id><pub-id pub-id-type="pmid">24759409</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>D.</given-names></name><name><surname>Sebat</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>CNVs: harbingers of a rare variant revolution in psychiatric genetics</article-title>. <source/>Cell
<volume>148</volume>, <fpage>1223</fpage>–<lpage>1241</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.039</pub-id><pub-id pub-id-type="pmid">22424231</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>S. E.</given-names></name><name><surname>Gillis</surname><given-names>J.</given-names></name><name><surname>Kramer</surname><given-names>M.</given-names></name><name><surname>Lihm</surname><given-names>J.</given-names></name><name><surname>Yoon</surname><given-names>S.</given-names></name><name><surname>Berstein</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title><italic>De novo</italic> mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability</article-title>. <source/>Mol. Psychiatry
<volume>19</volume>, <fpage>652</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2014.29</pub-id><pub-id pub-id-type="pmid">24776741</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>L. M.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Marshall</surname><given-names>C.</given-names></name><name><surname>Davis</surname><given-names>L. K.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study</article-title>. <source/>J. Am. Acad. Child Adolesc. Psychiatry
<volume>53</volume>, <fpage>910</fpage>–<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2014.04.022</pub-id><pub-id pub-id-type="pmid">25062598</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M. J.</given-names></name><name><surname>Beltrán</surname><given-names>J. F.</given-names></name><name><surname>Liang</surname><given-names>S.</given-names></name><name><surname>Fragoza</surname><given-names>R.</given-names></name><name><surname>Rumack</surname><given-names>A.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Interactome INSIDER: a structural interactome browser for genomic studies</article-title>. <source/>Nat. Methods
<volume>15</volume>, <fpage>107</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.4540</pub-id><pub-id pub-id-type="pmid">29355848</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelson</surname><given-names>J. J.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Gujral</surname><given-names>M.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Malhotra</surname><given-names>D.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Whole-Genome sequencing in autism identifies hot spots for <italic>de novo</italic> germline mutation</article-title>. <source/>Cell
<volume>151</volume>, <fpage>1431</fpage>–<lpage>1442</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.11.019</pub-id><pub-id pub-id-type="pmid">23260136</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>D. T.</given-names></name><name><surname>Adam</surname><given-names>M. P.</given-names></name><name><surname>Aradhya</surname><given-names>S.</given-names></name><name><surname>Biesecker</surname><given-names>L. G.</given-names></name><name><surname>Brothman</surname><given-names>A. R.</given-names></name><name><surname>Carter</surname><given-names>N. P.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies</article-title>. <source/>Am. J. Hum. Genet.
<volume>86</volume>, <fpage>749</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.006</pub-id><pub-id pub-id-type="pmid">20466091</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miosge</surname><given-names>L. A.</given-names></name><name><surname>Field</surname><given-names>M. A.</given-names></name><name><surname>Sontani</surname><given-names>Y.</given-names></name><name><surname>Cho</surname><given-names>V.</given-names></name><name><surname>Johnson</surname><given-names>S.</given-names></name><name><surname>Palkova</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Comparison of predicted and actual consequences of missense mutations</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>112</volume>, <fpage>E5189</fpage>–<lpage>E5198</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1511585112</pub-id><pub-id pub-id-type="pmid">26269570</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>K.</given-names></name><name><surname>Carvunis</surname><given-names>A.-R.</given-names></name><name><surname>Ramesh</surname><given-names>S. K.</given-names></name><name><surname>Ideker</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Integrative approaches for finding modular structure in biological networks</article-title>. <source/>Nat. Rev. Genet.
<volume>14</volume>, <fpage>719</fpage>–<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3552</pub-id><pub-id pub-id-type="pmid">24045689</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momozawa</surname><given-names>Y.</given-names></name><name><surname>Mni</surname><given-names>M.</given-names></name><name><surname>Nakamura</surname><given-names>K.</given-names></name><name><surname>Coppieters</surname><given-names>W.</given-names></name><name><surname>Almer</surname><given-names>S.</given-names></name><name><surname>Amininejad</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>43</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/ng.733</pub-id><pub-id pub-id-type="pmid">21151126</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moog</surname><given-names>U.</given-names></name></person-group> (<year>2005</year>). <article-title>The outcome of diagnostic studies on the etiology of mental retardation: considerations on the classification of the causes</article-title>. <source/>Am. J. Med. Genet. Part A
<volume>137A</volume>, <fpage>228</fpage>–<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.30841</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mort</surname><given-names>M.</given-names></name><name><surname>Sterne-Weiler</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Ball</surname><given-names>E. V.</given-names></name><name><surname>Cooper</surname><given-names>D. N.</given-names></name><name><surname>Radivojac</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>MutPred splice: machine learning-based prediction of exonic variants that disrupt splicing</article-title>. <source/>Genome Biol.
<volume>15</volume>:<fpage>R19</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2014-15-1-r19</pub-id><pub-id pub-id-type="pmid">24451234</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambot</surname><given-names>S.</given-names></name><name><surname>Thevenon</surname><given-names>J.</given-names></name><name><surname>Kuentz</surname><given-names>P.</given-names></name><name><surname>Duffourd</surname><given-names>Y.</given-names></name><name><surname>Tisserant</surname><given-names>E.</given-names></name><name><surname>Bruel</surname><given-names>A.-L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis</article-title>. <source/>Genet. Med.
<volume>20</volume>, <fpage>645</fpage>–<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2017.162</pub-id><pub-id pub-id-type="pmid">29095811</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Kou</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ma'ayan</surname><given-names>A.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Sabo</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Patterns and rates of exonic <italic>de novo</italic> mutations in autism spectrum disorders</article-title>. <source/>Nature
<volume>485</volume>, <fpage>242</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1038/nature11011</pub-id><pub-id pub-id-type="pmid">22495311</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>P. C.</given-names></name><name><surname>Henikoff</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>SIFT: predicting amino acid changes that affect protein function</article-title>. <source/>Nucleic Acids Res.
<volume>31</volume>, <fpage>3812</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id><pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>H. T.</given-names></name><name><surname>Bryois</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>A.</given-names></name><name><surname>Dobbyn</surname><given-names>A.</given-names></name><name><surname>Huckins</surname><given-names>L. M.</given-names></name><name><surname>Munoz-Manchado</surname><given-names>A. B.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders</article-title>. <source/>Genome Med.
<volume>9</volume>:<fpage>114</fpage>. <pub-id pub-id-type="doi">10.1186/s13073-017-0497-y</pub-id><pub-id pub-id-type="pmid">29262854</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname><given-names>A.</given-names></name><name><surname>Numata</surname><given-names>S.</given-names></name><name><surname>Tajima</surname><given-names>A.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Saito</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title><italic>De novo</italic> non-synonymous TBL1XR1 mutation alters Wnt signaling activity</article-title>. <source/>Sci. Rep.
<volume>7</volume>:<fpage>2887</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-02792-z</pub-id><pub-id pub-id-type="pmid">28588275</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nykamp</surname><given-names>K.</given-names></name><name><surname>Anderson</surname><given-names>M.</given-names></name><name><surname>Powers</surname><given-names>M.</given-names></name><name><surname>Garcia</surname><given-names>J.</given-names></name><name><surname>Herrera</surname><given-names>B.</given-names></name><name><surname>Ho</surname><given-names>Y.-Y.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria</article-title>. <source/>Genet. Med.
<volume>19</volume>, <fpage>1105</fpage>–<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2017.37</pub-id><pub-id pub-id-type="pmid">28492532</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Deriziotis</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Schwartz</surname><given-names>J. J.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe <italic>de novo</italic> mutations</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>585</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/ng.835</pub-id><pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Stessman</surname><given-names>H. A.</given-names></name><name><surname>Boyle</surname><given-names>E. A.</given-names></name><name><surname>Witherspoon</surname><given-names>K. T.</given-names></name><name><surname>Martin</surname><given-names>B.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Recurrent <italic>de novo</italic> mutations implicate novel genes underlying simplex autism risk</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>5595</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms6595</pub-id><pub-id pub-id-type="pmid">25418537</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Egertson</surname><given-names>J. D.</given-names></name><name><surname>Stanaway</surname><given-names>I. B.</given-names></name><name><surname>Phelps</surname><given-names>I. G.</given-names></name><etal></etal></person-group>. (<year>2012a</year>). <article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders</article-title>. <source/>Science
<volume>338</volume>, <fpage>1619</fpage>–<lpage>1622</lpage>. <pub-id pub-id-type="doi">10.1126/science.1227764</pub-id><pub-id pub-id-type="pmid">23160955</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group>. (<year>2012b</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of <italic>de novo</italic> mutations</article-title>. <source/>Nature
<volume>485</volume>, <fpage>246</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nature10989</pub-id><pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paneque</surname><given-names>M.</given-names></name><name><surname>Serra-Juhé</surname><given-names>C.</given-names></name><name><surname>Pestoff</surname><given-names>R.</given-names></name><name><surname>Cordier</surname><given-names>C.</given-names></name><name><surname>Silva</surname><given-names>J.</given-names></name><name><surname>Moldovan</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Complementarity between medical geneticists and genetic counsellors: its added value in genetic services in Europe</article-title>. <source/>Eur. J. Hum. Genet.
<volume>25</volume>, <fpage>918</fpage>–<lpage>923</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2017.76</pub-id><pub-id pub-id-type="pmid">28513616</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Gandal</surname><given-names>M. J.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders</article-title>. <source/>Nat. Rev. Genet.
<volume>16</volume>, <fpage>441</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3934</pub-id><pub-id pub-id-type="pmid">26149713</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Luo</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Lowe</surname><given-names>J. K.</given-names></name><name><surname>Chandran</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism</article-title>. <source/>Cell
<volume>155</volume>, <fpage>1008</fpage>–<lpage>1021</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.10.031</pub-id><pub-id pub-id-type="pmid">24267887</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Swarup</surname><given-names>V.</given-names></name><name><surname>Belgard</surname><given-names>T. G.</given-names></name><name><surname>Irimia</surname><given-names>M.</given-names></name><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Gandal</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Genome-wide changes in lncRNA, splicing and regional gene expression patterns in autism</article-title>. <source/>Nature
<volume>540</volume>, <fpage>423</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1038/nature20612</pub-id><pub-id pub-id-type="pmid">27919067</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>M. J.</given-names></name><name><surname>Fryer</surname><given-names>A. E.</given-names></name><name><surname>Shears</surname><given-names>D. J.</given-names></name><name><surname>Lachlan</surname><given-names>K. L.</given-names></name><name><surname>McKee</surname><given-names>S. A.</given-names></name><name><surname>Magee</surname><given-names>A. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title><italic>De novo</italic>, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability</article-title>. <source/>Am. J. Med. Genet. A
<volume>167A</volume>, <fpage>2231</fpage>–<lpage>2237</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37189</pub-id><pub-id pub-id-type="pmid">26079862</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasman</surname><given-names>J. A.</given-names></name><name><surname>Verweij</surname><given-names>K. J. H.</given-names></name><name><surname>Gerring</surname><given-names>Z.</given-names></name><name><surname>Stringer</surname><given-names>S.</given-names></name><name><surname>Sanchez-Roige</surname><given-names>S.</given-names></name><name><surname>Treur</surname><given-names>J. L.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia</article-title>. <source/>Nat. Neurosci.
<volume>21</volume>, <fpage>1161</fpage>–<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0206-1</pub-id><pub-id pub-id-type="pmid">30150663</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>K.</given-names></name><name><surname>Gavan</surname><given-names>S. P.</given-names></name><name><surname>Wright</surname><given-names>S. J.</given-names></name><name><surname>Thompson</surname><given-names>A. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Cost-effectiveness analyses of genetic and genomic diagnostic tests</article-title>. <source/>Nat. Rev. Genet.
<volume>19</volume>, <fpage>235</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1038/nrg.2017.108</pub-id><pub-id pub-id-type="pmid">29353875</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertea</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Salzberg</surname><given-names>S. L.</given-names></name></person-group> (<year>2001</year>). <article-title>GeneSplicer: a new computational method for splice site prediction</article-title>. <source/>Nucleic Acids Res.
<volume>29</volume>, <fpage>1185</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.5.1185</pub-id><pub-id pub-id-type="pmid">11222768</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippakis</surname><given-names>A. A.</given-names></name><name><surname>Azzariti</surname><given-names>D. R.</given-names></name><name><surname>Beltran</surname><given-names>S.</given-names></name><name><surname>Brookes</surname><given-names>A. J.</given-names></name><name><surname>Brownstein</surname><given-names>C. A.</given-names></name><name><surname>Brudno</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The matchmaker exchange: a platform for rare disease gene discovery</article-title>. <source/>Hum. Mutat.
<volume>36</volume>, <fpage>915</fpage>–<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22858</pub-id><pub-id pub-id-type="pmid">26295439</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>A. L.</given-names></name><name><surname>Zaitlen</surname><given-names>N. A.</given-names></name><name><surname>Reich</surname><given-names>D.</given-names></name><name><surname>Patterson</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>New approaches to population stratification in genome-wide association studies</article-title>. <source/>Nat. Rev. Genet.
<volume>11</volume>, <fpage>459</fpage>–<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2813</pub-id><pub-id pub-id-type="pmid">20548291</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prifti</surname><given-names>E.</given-names></name><name><surname>Zucker</surname><given-names>J.-D.</given-names></name><name><surname>Clément</surname><given-names>K.</given-names></name><name><surname>Henegar</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Interactional and functional centrality in transcriptional co-expression networks</article-title>. <source/>Bioinformatics
<volume>26</volume>, <fpage>3083</fpage>–<lpage>3089</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq591</pub-id><pub-id pub-id-type="pmid">20959383</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pullabhatla</surname><given-names>V.</given-names></name><name><surname>Roberts</surname><given-names>A. L.</given-names></name><name><surname>Lewis</surname><given-names>M. J.</given-names></name><name><surname>Mauro</surname><given-names>D.</given-names></name><name><surname>Morris</surname><given-names>D. L.</given-names></name><name><surname>Odhams</surname><given-names>C. A.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title><italic>De novo</italic> mutations implicate novel genes in systemic lupus erythematosus</article-title>. <source/>Hum. Mol. Genet.
<volume>27</volume>, <fpage>421</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx407</pub-id><pub-id pub-id-type="pmid">29177435</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname><given-names>A.</given-names></name><name><surname>Wieczorek</surname><given-names>D.</given-names></name><name><surname>Graf</surname><given-names>E.</given-names></name><name><surname>Wieland</surname><given-names>T.</given-names></name><name><surname>Endele</surname><given-names>S.</given-names></name><name><surname>Schwarzmayr</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study</article-title>. <source/>Lancet
<volume>380</volume>, <fpage>1674</fpage>–<lpage>1682</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(12)61480-9</pub-id><pub-id pub-id-type="pmid">23020937</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reese</surname><given-names>M. G.</given-names></name><name><surname>Eeckman</surname><given-names>F. H.</given-names></name><name><surname>Kulp</surname><given-names>D.</given-names></name><name><surname>Haussler</surname><given-names>D.</given-names></name></person-group> (<year>1997</year>). <article-title>Improved splice site detection in genie</article-title>. <source/>J. Comput. Biol.
<volume>4</volume>, <fpage>311</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1089/cmb.1997.4.311</pub-id><pub-id pub-id-type="pmid">9278062</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>S.</given-names></name><name><surname>Aziz</surname><given-names>N.</given-names></name><name><surname>Bale</surname><given-names>S.</given-names></name><name><surname>Bick</surname><given-names>D.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Gastier-Foster</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology</article-title>. <source/>Genet. Med.
<volume>17</volume>, <fpage>405</fpage>–<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id><pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rommelse</surname><given-names>N. N. J.</given-names></name><name><surname>Franke</surname><given-names>B.</given-names></name><name><surname>Geurts</surname><given-names>H. M.</given-names></name><name><surname>Hartman</surname><given-names>C. A.</given-names></name><name><surname>Buitelaar</surname><given-names>J. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder</article-title>. <source/>Eur. Child Adolesc. Psychiatry
<volume>19</volume>, <fpage>281</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-010-0092-x</pub-id><pub-id pub-id-type="pmid">20148275</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronald</surname><given-names>A.</given-names></name><name><surname>Simonoff</surname><given-names>E.</given-names></name><name><surname>Kuntsi</surname><given-names>J.</given-names></name><name><surname>Asherson</surname><given-names>P.</given-names></name><name><surname>Plomin</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample</article-title>. <source/>J. Child Psychol. Psychiatry
<volume>49</volume>, <fpage>535</fpage>–<lpage>542</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2007.01857.x</pub-id><pub-id pub-id-type="pmid">18221348</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>L.</given-names></name><name><surname>El-Khechen</surname><given-names>D.</given-names></name><name><surname>Black</surname><given-names>M. H.</given-names></name><name><surname>Farwell Hagman</surname><given-names>K. D.</given-names></name><name><surname>Tang</surname><given-names>S.</given-names></name><name><surname>Powis</surname><given-names>Z.</given-names></name></person-group> (<year>2017</year>). <article-title>Outcomes of diagnostic exome sequencing in patients with diagnosed or suspected autism spectrum disorders</article-title>. <source/>Pediatr. Neurol.
<volume>70</volume>, <fpage>34</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2017.01.033</pub-id><pub-id pub-id-type="pmid">28330790</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossin</surname><given-names>E. J.</given-names></name><name><surname>Lage</surname><given-names>K.</given-names></name><name><surname>Raychaudhuri</surname><given-names>S.</given-names></name><name><surname>Xavier</surname><given-names>R. J.</given-names></name><name><surname>Tatar</surname><given-names>D.</given-names></name><name><surname>Benita</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology</article-title>. <source/>PLoS Genet.
<volume>7</volume>:<fpage>e1001273</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1001273</pub-id><pub-id pub-id-type="pmid">21249183</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salakhutdinov</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Learning deep generative models</article-title>. <source/>Annu. Rev. Stat. Appl.
<volume>2</volume>, <fpage>361</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-statistics-010814-020120</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Robinson</surname><given-names>E. B.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Stevens</surname><given-names>C.</given-names></name><name><surname>Sabo</surname><given-names>A.</given-names></name><name><surname>McGrath</surname><given-names>L. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A framework for the interpretation of <italic>de novo</italic> mutation in human disease</article-title>. <source/>Nat. Genet.
<volume>46</volume>, <fpage>944</fpage>–<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3050</pub-id><pub-id pub-id-type="pmid">25086666</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Willsey</surname><given-names>A. J.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A. G.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Cicek</surname><given-names>A. E.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci</article-title>. <source/>Neuron
<volume>87</volume>, <fpage>1215</fpage>–<lpage>1233</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.016</pub-id><pub-id pub-id-type="pmid">26402605</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Murtha</surname><given-names>M. T.</given-names></name><name><surname>Gupta</surname><given-names>A. R.</given-names></name><name><surname>Murdoch</surname><given-names>J. D.</given-names></name><name><surname>Raubeson</surname><given-names>M. J.</given-names></name><name><surname>Willsey</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title><italic>De novo</italic> mutations revealed by whole-exome sequencing are strongly associated with autism</article-title>. <source/>Nature
<volume>485</volume>, <fpage>237</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1038/nature10945</pub-id><pub-id pub-id-type="pmid">22495306</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sauna</surname><given-names>Z. E.</given-names></name><name><surname>Kimchi-Sarfaty</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Synonymous Mutations as a Cause of Human Genetic Disease</article-title>, <source/>in eLS (<publisher-loc>Chichester</publisher-loc>: <publisher-name>John Wiley &amp; Sons, Ltd</publisher-name>). <pub-id pub-id-type="doi">10.1002/9780470015902.a0025173</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><name><surname>Ripke</surname><given-names>S.</given-names></name><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Corvin</surname><given-names>A.</given-names></name><name><surname>Walters</surname><given-names>J. T. R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source/>Nature
<volume>511</volume>, <fpage>421</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1038/nature13595</pub-id><pub-id pub-id-type="pmid">25056061</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>J. M.</given-names></name><name><surname>Cooper</surname><given-names>D. N.</given-names></name><name><surname>Schuelke</surname><given-names>M.</given-names></name><name><surname>Seelow</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>MutationTaster2: mutation prediction for the deep-sequencing age</article-title>. <source/>Nat. Methods
<volume>11</volume>, <fpage>361</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2890</pub-id><pub-id pub-id-type="pmid">24681721</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebat</surname><given-names>J.</given-names></name><name><surname>Lakshmi</surname><given-names>B.</given-names></name><name><surname>Malhotra</surname><given-names>D.</given-names></name><name><surname>Troge</surname><given-names>J.</given-names></name><name><surname>Lese-Martin</surname><given-names>C.</given-names></name><name><surname>Walsh</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Strong association of <italic>de novo</italic> copy number mutations with autism</article-title>. <source/>Science
<volume>316</volume>, <fpage>445</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1126/science.1138659</pub-id><pub-id pub-id-type="pmid">17363630</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shashi</surname><given-names>V.</given-names></name><name><surname>McConkie-Rosell</surname><given-names>A.</given-names></name><name><surname>Rosell</surname><given-names>B.</given-names></name><name><surname>Schoch</surname><given-names>K.</given-names></name><name><surname>Vellore</surname><given-names>K.</given-names></name><name><surname>McDonald</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders</article-title>. <source/>Genet. Med.
<volume>16</volume>, <fpage>176</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2013.99</pub-id><pub-id pub-id-type="pmid">23928913</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Analysis of misdiagnosis of bipolar disorder in an outpatient setting</article-title>. <source/>Shanghai Arch. Psychiatry
<volume>30</volume>, <fpage>93</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.11919/j.issn.1002-0829.217080</pub-id><pub-id pub-id-type="pmid">29736129</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherry</surname><given-names>S. T.</given-names></name><name><surname>Ward</surname><given-names>M. H.</given-names></name><name><surname>Kholodov</surname><given-names>M.</given-names></name><name><surname>Baker</surname><given-names>J.</given-names></name><name><surname>Phan</surname><given-names>L.</given-names></name><name><surname>Smigielski</surname><given-names>E. M.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>dbSNP: the NCBI database of genetic variation</article-title>. <source/>Nucleic Acids Res.
<volume>29</volume>, <fpage>308</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id><pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shihab</surname><given-names>H. A.</given-names></name><name><surname>Rogers</surname><given-names>M. F.</given-names></name><name><surname>Gough</surname><given-names>J.</given-names></name><name><surname>Mort</surname><given-names>M.</given-names></name><name><surname>Cooper</surname><given-names>D. N.</given-names></name><name><surname>Day</surname><given-names>I. N. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>An integrative approach to predicting the functional effects of non-coding and coding sequence variation</article-title>. <source/>Bioinformatics
<volume>31</volume>, <fpage>1536</fpage>–<lpage>1543</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv009</pub-id><pub-id pub-id-type="pmid">25583119</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shohat</surname><given-names>S.</given-names></name><name><surname>Ben-David</surname><given-names>E.</given-names></name><name><surname>Shifman</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Varying intolerance of gene pathways to mutational classes explain genetic convergence across neuropsychiatric disorders</article-title>. <source/>Cell Rep.
<volume>18</volume>, <fpage>2217</fpage>–<lpage>2227</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.02.007</pub-id><pub-id pub-id-type="pmid">28249166</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>P. J.</given-names></name><name><surname>McRae</surname><given-names>J. F.</given-names></name><name><surname>Gallone</surname><given-names>G.</given-names></name><name><surname>Sifrim</surname><given-names>A.</given-names></name><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title><italic>De novo</italic> mutations in regulatory elements in neurodevelopmental disorders</article-title>. <source/>Nature
<volume>555</volume>, <fpage>611</fpage>–<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1038/nature25983</pub-id><pub-id pub-id-type="pmid">29562236</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smedemark-Margulies</surname><given-names>N.</given-names></name><name><surname>Brownstein</surname><given-names>C. A.</given-names></name><name><surname>Vargas</surname><given-names>S.</given-names></name><name><surname>Tembulkar</surname><given-names>S. K.</given-names></name><name><surname>Towne</surname><given-names>M. C.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>A novel <italic>de novo</italic> mutation in ATP1A3 and childhood-onset schizophrenia</article-title>. <source/>Cold Spring Harb. Mol. Case Stud.
<volume>2</volume>, <fpage>a001008</fpage>. <pub-id pub-id-type="doi">10.1101/mcs.a001008</pub-id><pub-id pub-id-type="pmid">27626066</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E. D.</given-names></name><name><surname>Radtke</surname><given-names>K.</given-names></name><name><surname>Rossi</surname><given-names>M.</given-names></name><name><surname>Shinde</surname><given-names>D. N.</given-names></name><name><surname>Darabi</surname><given-names>S.</given-names></name><name><surname>El-Khechen</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Classification of genes: standardized clinical validity assessment of gene-disease associations aids diagnostic exome analysis and reclassifications</article-title>. <source/>Hum. Mutat.
<volume>38</volume>, <fpage>600</fpage>–<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23183</pub-id><pub-id pub-id-type="pmid">28106320</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stankiewicz</surname><given-names>P.</given-names></name><name><surname>Lupski</surname><given-names>J. R.</given-names></name></person-group> (<year>2010</year>). <article-title>Structural variation in the human genome and its role in disease</article-title>. <source/>Annu. Rev. Med.
<volume>61</volume>, <fpage>437</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-med-100708-204735</pub-id><pub-id pub-id-type="pmid">20059347</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>Z.</given-names></name><name><surname>Tan</surname><given-names>T. Y.</given-names></name><name><surname>Chong</surname><given-names>B.</given-names></name><name><surname>Brett</surname><given-names>G. R.</given-names></name><name><surname>Yap</surname><given-names>P.</given-names></name><name><surname>Walsh</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders</article-title>. <source/>Genet. Med.
<volume>18</volume>, <fpage>1090</fpage>–<lpage>1096</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2016.1</pub-id><pub-id pub-id-type="pmid">26938784</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenson</surname><given-names>P. D.</given-names></name><name><surname>Mort</surname><given-names>M.</given-names></name><name><surname>Ball</surname><given-names>E. V.</given-names></name><name><surname>Evans</surname><given-names>K.</given-names></name><name><surname>Hayden</surname><given-names>M.</given-names></name><name><surname>Heywood</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>The human gene mutation database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies</article-title>. <source/>Hum. Genet.
<volume>136</volume>, <fpage>665</fpage>–<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-017-1779-6</pub-id><pub-id pub-id-type="pmid">28349240</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stessman</surname><given-names>H. A. F.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Hoekzema</surname><given-names>K.</given-names></name><name><surname>Fenckova</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases</article-title>. <source/>Nat. Genet.
<volume>49</volume>, <fpage>515</fpage>–<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3792</pub-id><pub-id pub-id-type="pmid">28191889</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strovel</surname><given-names>E. T.</given-names></name><name><surname>Cowan</surname><given-names>T. M.</given-names></name><name><surname>Scott</surname><given-names>A. I.</given-names></name><name><surname>Wolf</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics</article-title>. <source/>Genet. Med.
<volume>19</volume>:<fpage>1079</fpage>. <pub-id pub-id-type="doi">10.1038/gim.2017.84</pub-id><pub-id pub-id-type="pmid">28682309</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>J. M.</given-names></name><name><surname>Segal</surname><given-names>E.</given-names></name><name><surname>Koller</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>S. K.</given-names></name></person-group> (<year>2003</year>). <article-title>A gene-coexpression network for global discovery of conserved genetic modules</article-title>. <source/>Science
<volume>302</volume>, <fpage>249</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1126/science.1087447</pub-id><pub-id pub-id-type="pmid">12934013</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>P. F.</given-names></name></person-group> (<year>2010</year>). <article-title>The psychiatric GWAS consortium: big science comes to psychiatry</article-title>. <source/>Neuron
<volume>68</volume>, <fpage>182</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.10.003</pub-id><pub-id pub-id-type="pmid">20955924</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>P. F.</given-names></name><name><surname>Daly</surname><given-names>M. J.</given-names></name><name><surname>O'Donovan</surname><given-names>M.</given-names></name></person-group> (<year>2012a</year>). <article-title>Genetic architectures of psychiatric disorders: the emerging picture and its implications</article-title>. <source/>Nat. Rev. Genet.
<volume>13</volume>, <fpage>537</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3240</pub-id><pub-id pub-id-type="pmid">22777127</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>P. F.</given-names></name><name><surname>Magnusson</surname><given-names>C.</given-names></name><name><surname>Reichenberg</surname><given-names>A.</given-names></name><name><surname>Boman</surname><given-names>M.</given-names></name><name><surname>Dalman</surname><given-names>C.</given-names></name><name><surname>Davidson</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012b</year>). <article-title>Family history of schizophrenia and bipolar disorder as risk factors for autism</article-title>. <source/>Arch. Gen. Psychiatry
<volume>69</volume>, <fpage>1099</fpage>–<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2012.730</pub-id><pub-id pub-id-type="pmid">22752149</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>M.</given-names></name><name><surname>Chin</surname><given-names>C. H.</given-names></name><name><surname>Lim</surname><given-names>C. G.</given-names></name><name><surname>Liew</surname><given-names>H. S. A.</given-names></name><name><surname>Lim</surname><given-names>C. S.</given-names></name><name><surname>Kashala</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>What's in the pipeline? Drugs in development for autism spectrum disorder</article-title>. <source/>Neuropsychiatr. Dis. Treat.
<volume>10</volume>, <fpage>371</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S39516</pub-id><pub-id pub-id-type="pmid">24591832</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>A.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Ionita-Laza</surname><given-names>I.</given-names></name><name><surname>Roos</surname><given-names>J. L.</given-names></name><name><surname>Gogos</surname><given-names>J. A.</given-names></name><name><surname>Karayiorgou</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Loss-of-Function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene</article-title>. <source/>Neuron
<volume>82</volume>, <fpage>773</fpage>–<lpage>780</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.04.043</pub-id><pub-id pub-id-type="pmid">24853937</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammimies</surname><given-names>K.</given-names></name><name><surname>Marshall</surname><given-names>C. R.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><name><surname>Kaur</surname><given-names>G.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Lionel</surname><given-names>A. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder</article-title>. <source/>JAMA
<volume>314</volume>, <fpage>895</fpage>–<lpage>903</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2015.10078</pub-id><pub-id pub-id-type="pmid">26325558</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telenti</surname><given-names>A.</given-names></name><name><surname>Lippert</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>P.-C.</given-names></name><name><surname>DePristo</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Deep learning of genomic variation and regulatory network data</article-title>. <source/>Hum. Mol. Genet.
<volume>27</volume>, <fpage>R63</fpage>–<lpage>R71</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy115</pub-id><pub-id pub-id-type="pmid">29648622</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teslovich</surname><given-names>T. M.</given-names></name><name><surname>Musunuru</surname><given-names>K.</given-names></name><name><surname>Smith</surname><given-names>A. V.</given-names></name><name><surname>Edmondson</surname><given-names>A. C.</given-names></name><name><surname>Stylianou</surname><given-names>I. M.</given-names></name><name><surname>Koseki</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Biological, clinical and population relevance of 95 loci for blood lipids</article-title>. <source/>Nature
<volume>466</volume>, <fpage>707</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1038/nature09270</pub-id><pub-id pub-id-type="pmid">20686565</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>The Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium</collab></person-group> (<year>2017</year>). <article-title>Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia</article-title>. <source/>Mol. Autism
<volume>8</volume>:<fpage>21</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-017-0137-9</pub-id><pub-id pub-id-type="pmid">28540026</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tlemsani</surname><given-names>C.</given-names></name><name><surname>Luscan</surname><given-names>A.</given-names></name><name><surname>Leulliot</surname><given-names>N.</given-names></name><name><surname>Bieth</surname><given-names>E.</given-names></name><name><surname>Afenjar</surname><given-names>A.</given-names></name><name><surname>Baujat</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>SETD2 and DNMT3A screen in the Sotos-like syndrome French cohort</article-title>. <source/>J. Med. Genet.
<volume>53</volume>, <fpage>743</fpage>–<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103638</pub-id><pub-id pub-id-type="pmid">27317772</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trampush</surname><given-names>J. W.</given-names></name><name><surname>Yang</surname><given-names>M. L. Z.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Knowles</surname><given-names>E.</given-names></name><name><surname>Davies</surname><given-names>G.</given-names></name><name><surname>Liewald</surname><given-names>D. C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium</article-title>. <source/>Mol. Psychiatry
<volume>22</volume>, <fpage>336</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2016.244</pub-id><pub-id pub-id-type="pmid">28093568</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trost</surname><given-names>B.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>MacDonald</surname><given-names>J. R.</given-names></name><name><surname>Sung</surname><given-names>W. W. L.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>A Comprehensive workflow for read depth-based identification of copy-number variation from whole-genome sequence data</article-title>. <source/>Am. J. Hum. Genet.
<volume>102</volume>, <fpage>142</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.12.007</pub-id><pub-id pub-id-type="pmid">29304372</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>T. N.</given-names></name><name><surname>Hormozdiari</surname><given-names>F.</given-names></name><name><surname>Duyzend</surname><given-names>M. H.</given-names></name><name><surname>McClymont</surname><given-names>S. A.</given-names></name><name><surname>Hook</surname><given-names>P. W.</given-names></name><name><surname>Iossifov</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Genome sequencing of autism-affected families reveals disruption of putative noncoding regulatory DNA</article-title>. <source/>Am. J. Hum. Genet.
<volume>98</volume>, <fpage>58</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2015.11.023</pub-id><pub-id pub-id-type="pmid">26749308</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>T. N.</given-names></name><name><surname>Yi</surname><given-names>Q.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Huddleston</surname><given-names>J.</given-names></name><name><surname>Hoekzema</surname><given-names>K.</given-names></name><name><surname>F. Stessman</surname><given-names>H. A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>denovo-db: a compendium of human <italic>de novo</italic> variants</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>D804</fpage>–<lpage>D811</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw865</pub-id><pub-id pub-id-type="pmid">27907889</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Bon</surname><given-names>B. W. M.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Bernier</surname><given-names>R.</given-names></name><name><surname>Green</surname><given-names>C.</given-names></name><name><surname>Gerdts</surname><given-names>J.</given-names></name><name><surname>Witherspoon</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Disruptive <italic>de novo</italic> mutations of DYRK1A lead to a syndromic form of autism and ID</article-title>. <source/>Mol. Psychiatry
<volume>21</volume>, <fpage>126</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.5</pub-id><pub-id pub-id-type="pmid">25707398</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Dam</surname><given-names>S.</given-names></name><name><surname>Võsa</surname><given-names>U.</given-names></name><name><surname>van der Graaf</surname><given-names>A.</given-names></name><name><surname>Franke</surname><given-names>L.</given-names></name><name><surname>de Magalhães</surname><given-names>J. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Gene co-expression analysis for functional classification and gene–disease predictions</article-title>. <source/>Brief. Bioinform.
<volume>19</volume>:<fpage>bbw139</fpage>. <pub-id pub-id-type="doi">10.1093/bib/bbw139</pub-id><pub-id pub-id-type="pmid">28077403</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Karnebeek</surname><given-names>C. D. M.</given-names></name><name><surname>Jansweijer</surname><given-names>M. C. E.</given-names></name><name><surname>Leenders</surname><given-names>A. G. E.</given-names></name><name><surname>Offringa</surname><given-names>M.</given-names></name><name><surname>Hennekam</surname><given-names>R. C. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness</article-title>. <source/>Eur. J. Hum. Genet.
<volume>13</volume>, <fpage>6</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201279</pub-id><pub-id pub-id-type="pmid">15523501</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veeramah</surname><given-names>K. R.</given-names></name><name><surname>Johnstone</surname><given-names>L.</given-names></name><name><surname>Karafet</surname><given-names>T. M.</given-names></name><name><surname>Wolf</surname><given-names>D.</given-names></name><name><surname>Sprissler</surname><given-names>R.</given-names></name><name><surname>Salogiannis</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Exome sequencing reveals new causal mutations in children with epileptic encephalopathies</article-title>. <source/>Epilepsia
<volume>54</volume>, <fpage>1270</fpage>–<lpage>1281</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12201</pub-id><pub-id pub-id-type="pmid">23647072</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veltman</surname><given-names>J. A.</given-names></name><name><surname>Brunner</surname><given-names>H. G.</given-names></name></person-group> (<year>2012</year>). <article-title><italic>De novo</italic> mutations in human genetic disease</article-title>. <source/>Nat. Rev. Genet.
<volume>13</volume>, <fpage>565</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3241</pub-id><pub-id pub-id-type="pmid">22805709</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visscher</surname><given-names>P. M.</given-names></name><name><surname>Brown</surname><given-names>M. A.</given-names></name><name><surname>McCarthy</surname><given-names>M. I.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Five years of GWAS discovery</article-title>. <source/>Am. J. Hum. Genet.
<volume>90</volume>, <fpage>7</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.11.029</pub-id><pub-id pub-id-type="pmid">22243964</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visscher</surname><given-names>P. M.</given-names></name><name><surname>Wray</surname><given-names>N. R.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Sklar</surname><given-names>P.</given-names></name><name><surname>McCarthy</surname><given-names>M. I.</given-names></name><name><surname>Brown</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>10 years of GWAS Discovery: biology, function, and translation</article-title>. <source/>Am. J. Hum. Genet.
<volume>101</volume>, <fpage>5</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2017.06.005</pub-id><pub-id pub-id-type="pmid">28686856</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>L. E. L. M.</given-names></name><name><surname>de Ligt</surname><given-names>J.</given-names></name><name><surname>Gilissen</surname><given-names>C.</given-names></name><name><surname>Janssen</surname><given-names>I.</given-names></name><name><surname>Steehouwer</surname><given-names>M.</given-names></name><name><surname>de Vries</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A <italic>de novo</italic> paradigm for mental retardation</article-title>. <source/>Nat. Genet.
<volume>42</volume>, <fpage>1109</fpage>–<lpage>1112</lpage>. <pub-id pub-id-type="doi">10.1038/ng.712</pub-id><pub-id pub-id-type="pmid">21076407</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>L. E. L. M.</given-names></name><name><surname>van Nimwegen</surname><given-names>K. J. M.</given-names></name><name><surname>Schieving</surname><given-names>J. H.</given-names></name><name><surname>Kamsteeg</surname><given-names>E.-J.</given-names></name><name><surname>Kleefstra</surname><given-names>T.</given-names></name><name><surname>Yntema</surname><given-names>H. G.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology</article-title>. <source/>Genet. Med.
<volume>19</volume>, <fpage>1055</fpage>–<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2017.1</pub-id><pub-id pub-id-type="pmid">28333917</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voight</surname><given-names>B. F.</given-names></name><name><surname>Scott</surname><given-names>L. J.</given-names></name><name><surname>Steinthorsdottir</surname><given-names>V.</given-names></name><name><surname>Morris</surname><given-names>A. P.</given-names></name><name><surname>Dina</surname><given-names>C.</given-names></name><name><surname>Welch</surname><given-names>R. P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis</article-title>. <source/>Nat. Genet.
<volume>42</volume>, <fpage>579</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/ng.609</pub-id><pub-id pub-id-type="pmid">20581827</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Hakonarson</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source/>Nucleic Acids Res.
<volume>38</volume>:<fpage>e164</fpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id><pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>H.</given-names></name><name><surname>Xiong</surname><given-names>B.</given-names></name><name><surname>Stessman</surname><given-names>H. A. F.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title><italic>De novo</italic> genic mutations among a Chinese autism spectrum disorder cohort</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>13316</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms13316</pub-id><pub-id pub-id-type="pmid">27824329</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanke</surname><given-names>K. A.</given-names></name><name><surname>Devanna</surname><given-names>P.</given-names></name><name><surname>Vernes</surname><given-names>S. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Understanding neurodevelopmental disorders: the promise of regulatory variation in the 3'UTRome</article-title>. <source/>Biol. Psychiatry
<volume>83</volume>, <fpage>548</fpage>–<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.11.006</pub-id><pub-id pub-id-type="pmid">29289333</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weckselblatt</surname><given-names>B.</given-names></name><name><surname>Rudd</surname><given-names>M. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Human structural variation: mechanisms of chromosome rearrangements</article-title>. <source/>Trends Genet.
<volume>31</volume>, <fpage>587</fpage>–<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2015.05.010</pub-id><pub-id pub-id-type="pmid">26209074</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenger</surname><given-names>A. M.</given-names></name><name><surname>Guturu</surname><given-names>H.</given-names></name><name><surname>Bernstein</surname><given-names>J. A.</given-names></name><name><surname>Bejerano</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers</article-title>. <source/>Genet. Med.
<volume>19</volume>, <fpage>209</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2016.88</pub-id><pub-id pub-id-type="pmid">27441994</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werling</surname><given-names>D. M.</given-names></name><name><surname>Brand</surname><given-names>H.</given-names></name><name><surname>An</surname><given-names>J.-Y.</given-names></name><name><surname>Stone</surname><given-names>M. R.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Glessner</surname><given-names>J. T.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder</article-title>. <source/>Nat. Genet.
<volume>50</volume>, <fpage>727</fpage>–<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-018-0107-y</pub-id><pub-id pub-id-type="pmid">29700473</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilfert</surname><given-names>A. B.</given-names></name><name><surname>Sulovari</surname><given-names>A.</given-names></name><name><surname>Turner</surname><given-names>T. N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Eichler</surname><given-names>E. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Recurrent <italic>de novo</italic> mutations in neurodevelopmental disorders: properties and clinical implications</article-title>. <source/>Genome Med.
<volume>9</volume>:<fpage>101</fpage>. <pub-id pub-id-type="doi">10.1186/s13073-017-0498-x</pub-id><pub-id pub-id-type="pmid">29179772</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willsey</surname><given-names>A. J.</given-names></name><name><surname>Fernandez</surname><given-names>T. V.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>King</surname><given-names>R. A.</given-names></name><name><surname>Dietrich</surname><given-names>A.</given-names></name><name><surname>Xing</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title><italic>De Novo</italic> coding variants are strongly associated with tourette disorder</article-title>. <source/>Neuron
<volume>94</volume>, <fpage>486</fpage>–<lpage>499.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.024</pub-id><pub-id pub-id-type="pmid">28472652</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willsey</surname><given-names>A. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Tebbenkamp</surname><given-names>A. T.</given-names></name><name><surname>Muhle</surname><given-names>R. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism</article-title>. <source/>Cell
<volume>155</volume>, <fpage>997</fpage>–<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.10.020</pub-id><pub-id pub-id-type="pmid">24267886</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>C. F.</given-names></name><name><surname>FitzPatrick</surname><given-names>D. R.</given-names></name><name><surname>Firth</surname><given-names>H. V.</given-names></name></person-group> (<year>2018</year>). <article-title>Paediatric genomics: diagnosing rare disease in children</article-title>. <source/>Nat. Rev. Genet.
<volume>19</volume>, <fpage>253</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1038/nrg.2017.116</pub-id><pub-id pub-id-type="pmid">29398702</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Ionita-Laza</surname><given-names>I.</given-names></name><name><surname>Roos</surname><given-names>J. L.</given-names></name><name><surname>Boone</surname><given-names>B.</given-names></name><name><surname>Woodrick</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title><italic>De novo</italic> gene mutations highlight patterns of genetic and neural complexity in schizophrenia</article-title>. <source/>Nat. Genet.
<volume>44</volume>, <fpage>1365</fpage>–<lpage>1369</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2446</pub-id><pub-id pub-id-type="pmid">23042115</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Roos</surname><given-names>J. L.</given-names></name><name><surname>Dexheimer</surname><given-names>P.</given-names></name><name><surname>Boone</surname><given-names>B.</given-names></name><name><surname>Plummer</surname><given-names>B.</given-names></name><name><surname>Levy</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Exome sequencing supports a <italic>de novo</italic> mutational paradigm for schizophrenia</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>864</fpage>–<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1038/ng.902</pub-id><pub-id pub-id-type="pmid">21822266</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Muzny</surname><given-names>D. M.</given-names></name><name><surname>Reid</surname><given-names>J. G.</given-names></name><name><surname>Bainbridge</surname><given-names>M. N.</given-names></name><name><surname>Willis</surname><given-names>A.</given-names></name><name><surname>Ward</surname><given-names>P. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Clinical whole-exome sequencing for the diagnosis of mendelian disorders</article-title>. <source/>N. Engl. J. Med.
<volume>369</volume>, <fpage>1502</fpage>–<lpage>1511</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1306555</pub-id><pub-id pub-id-type="pmid">24088041</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Muzny</surname><given-names>D. M.</given-names></name><name><surname>Xia</surname><given-names>F.</given-names></name><name><surname>Niu</surname><given-names>Z.</given-names></name><name><surname>Person</surname><given-names>R.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Molecular findings among patients referred for clinical whole-exome sequencing</article-title>. <source/>JAMA
<volume>312</volume>, <fpage>1870</fpage>–<lpage>1879</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.14601</pub-id><pub-id pub-id-type="pmid">25326635</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>R. K. C</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Bookman</surname><given-names>M.</given-names></name><name><surname>Howe</surname><given-names>L. J.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>602</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4524</pub-id><pub-id pub-id-type="pmid">28263302</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>R. K. C.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name><name><surname>Pellecchia</surname><given-names>G.</given-names></name><name><surname>Alipanahi</surname><given-names>B.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Genome-wide characteristics of <italic>de novo</italic> mutations in autism</article-title>. <source/>NPJ Genomic Med.
<volume>1</volume>, <fpage>160271</fpage>–<lpage>1602710</lpage>. <pub-id pub-id-type="doi">10.1038/npjgenmed.2016.27</pub-id><pub-id pub-id-type="pmid">27525107</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>R. K. C.</given-names></name><name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name><name><surname>Merico</surname><given-names>D.</given-names></name><name><surname>Walker</surname><given-names>S.</given-names></name><name><surname>Tammimies</surname><given-names>K.</given-names></name><name><surname>Hoang</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Whole-genome sequencing of quartet families with autism spectrum disorder</article-title>. <source/>Nat. Med.
<volume>21</volume>, <fpage>185</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3792</pub-id><pub-id pub-id-type="pmid">25621899</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>A General framework for weighted gene co-expression network analysis</article-title>. <source/>Stat. Appl. Genet. Mol. Biol.
<volume>4</volume>:<fpage>17</fpage>. <pub-id pub-id-type="doi">10.2202/1544-6115.1128</pub-id><pub-id pub-id-type="pmid">16646834</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Troyanskaya</surname><given-names>O. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Predicting effects of noncoding variants with deep learning-based sequence model</article-title>. <source/>Nat. Methods
<volume>12</volume>, <fpage>931</fpage>–<lpage>934</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3547</pub-id><pub-id pub-id-type="pmid">26301843</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Vetrini</surname><given-names>F.</given-names></name><name><surname>Braxton</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Two <italic>de novo</italic> novel mutations in one <italic>SHANK3</italic> allele in a patient with autism and moderate intellectual disability</article-title>. <source/>Am. J. Med. Genet. Part A
<volume>176</volume>, <fpage>973</fpage>–<lpage>979</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38622</pub-id><pub-id pub-id-type="pmid">29423971</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Need</surname><given-names>A. C.</given-names></name><name><surname>Petrovski</surname><given-names>S.</given-names></name><name><surname>Goldstein</surname><given-names>D. B.</given-names></name></person-group> (<year>2014</year>). <article-title>One gene, many neuropsychiatric disorders: lessons from Mendelian diseases</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>773</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3713</pub-id><pub-id pub-id-type="pmid">24866043</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>